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Horizontal gene transfer drives bacterial evolution and is crucial for the patho-
genicity of many bacteria that can exchange genetic material through distinct 
mechanisms such as natural transformation. S. pneumoniae, a common asympto-
matic colonizer of the human nasopharynx, is naturally transformable, being able 
to take up naked DNA and integrate it into its genome. Natural transformation 
allows pneumococci to acquire new traits, which can provide fitness advantages 
and contribute to the modulation of carriage and invasive diseases such as pneu-
monia, meningitis or septicaemia.
Natural transformation is a complex and highly regulated process, which requires 
bacteria to enter in a distinct metabolic state named competence. During this 
period, competent pneumococci express all proteins required for transformation. 
Among them, are the proteins encoded by the comG operon (comGA-G) impli-
cated in the assembly of pneumococcal competence type IV pili (T4P), which were 
shown to directly bind DNA. Deciphering how these filaments are assembled is 
a crucial step in understanding pneumococcal natural transformation and the 
main focus of this thesis.
Pneumococcal T4P can be several micrometres long and are composed of the major 
pilin ComGC. We demonstrated that ComGC has intrinsic capacity to polymerize 
and to assemble into pili. We also solved the high-resolution NMR structure of 
N-terminal truncated ComGC and found that ComGC has distinct structural fea-
tures compared to other known type IV pilins and is highly flexible. Based on the 
structure of ComGC, we further identified a region with potential DNA binding 
properties, providing the basis to understand the function of competence pili. In 
addition to our investigation of the major pilin ComGC, we also studied the role 
of the minor pilins ComGD, ComGE, CopmGF and ComGG in pilus assembly and 
transformation. We showed that the pneumococcal minor pilins form a minor 
pilin complex likely to prime pilus assembly. Moreover, we visualized that ComGF 
is part of the filament and present strong evidence for the role of ComGG as the 
linker between the minor pilin complex and ComGC.
Pneumococcal colonization and virulence can be influenced by different factors 
including induction of competence genes and cell morphology. We found that 
Deterministic Lateral Displacement is a suitable label-free microfluidics technique 
to sort S. pneumoniae into subpopulations based on morphological properties, 
which can be a relevant tool to understand the mechanisms governing coloniza-
tion and how bacteria cause disease. 
In summary, here we provide a genetic and molecular characterization of the 
key components involved in pneumococcal pilus assembly and present a novel 
technique to study S. pneumoniae subpopulations.  
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1.1 Horizontal gene transfer in bacteria
Bacteria are able to exchange genetic material, a process commonly referred to 
as lateral or horizontal gene transfer (HGT). Horizontal gene transfer allows bac-
teria to acquire new genetic material from other bacteria thereby contributing 
to their genomic diversity and potentially increasing their evolutionary fitness. 
The exchange of genetic material among bacteria can occur through different 
mechanisms. In this section, a brief overview of the main mechanisms including 
conjugation, transduction and transformation and their impact will be presented. 
1.1.1 Conjugation
Conjugation is the mechanism whereby a donor bacterium exchanges genetic 
material with a recipient bacterium. The process is well-conserved among Gram-
negative and Gram-positive bacteria as well as archaea (1). The genetic material 
transferred during conjugation can either be conjugative plasmids or integrative 
conjugative elements (ICEs). The major difference between them is that, once 
transferred to the recipient bacterium, conjugative plasmids remain as extra chro-
mosomal elements and replicate independently, whereas ICEs need to be inte-
grated into the bacterial genome to be able to propagate during cell division (2). 
Conjugation requires direct cell-to-cell contact between donor and recipient 
bacteria through the formation of a conjugation pilus. The assembly of conjuga-
tive pili requires a sophisticated type IV secretion system (T4SS) also known as 
transferosome (3). The pilus is assembled by the donor bacterium and establishes 
the interaction with the recipient bacterium. This donor-recipient interaction 
is also called mating pair formation and it is crucial for DNA translocation. The 
exact mechanism through which the mating pair is formed remains elusive. In 
Gram-negative bacteria, interactions between an adhesin present on the pilus 
tip of the donor bacterium, with the lipopolysaccharides (LPS) on the surface of 
recipient bacteria have been reported (4). However, another study showed that 
mutations in the LPS synthesis pathway had only a modest impact on conjuga-
tion (5). Once the mating pair is formed, the pilus retracts, bringing donor and 
recipient bacteria in close proximity. Then, a signal is transmitted to the trans-
ferosome indicating that DNA processing and transfer should be initiated (6). This 
signal is produced by the recipient bacterium. It can either be peptides acting 
as pheromones or signal peptides secreted in a cell density-dependent manner 
and regulated by quorum-sensing (2, 7). The signal is then sensed by the donor 
bacterium and transferred along the transferosome to another complex named 
relaxosome. The relaxosome is formed by a conjugative DNA-processing enzyme 
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(relaxase) and accessory proteins bound to a specific DNA sequence called ori-
gin of transfer (oriT) (8). Relaxases create site- and strand specific nicks within 
oriT thereby processing and preparing the transfer of single-strand DNA. The 
interaction between the transferosome and the relaxosome is established with 
the help of a protein named type IV coupling protein (T4CP) (9, 10). T4CP is a 
crucial intermediate, which responds to the DNA transfer activation signals, and 
it mediates the relaxase-DNA complex translocation through the transferosome 
into the recipient bacterium. Finally, once in the recipient cell, the incoming DNA 
is recircularized by the relaxase and the complementary strand is synthesized to 
generate stable transconjugants (2, 11). 
Conjugation has been extensively studied in the F-plasmid transfer system in 
Escherichia coli and in F-like plasmid systems in association with the spread of 
antibiotic resistance genes (12). Inhibiting conjugation is therefore an attractive 
approach to tackle antimicrobial resistance and the spread of diseases. However, 
conjugation is not only restricted to bacterial cells as donor and recipient, as the 
plant pathogen Agrobacterium tumefaciens has the ability to use conjugation to 
transfer oncogenic DNA into plant cells to cause crown gall disease  (13). 
1.1.2 Transduction
Transduction refers to the exchange of DNA carried out with the help of bac-
teriophages (or phages), transferring DNA from one bacterium to another. 
Bacteriophages are viruses that infect and replicate only in bacteria. These viral 
particles are extremely diverse in size, morphology, and in genomic organization, 
but typically consist of genomic material enclosed in a phage-encoded capsid 
(head), which protects and mediates its delivery into the next host bacterial cell 
(14). In lysogenic bacteria, phages are integrated into the host bacterial genome 
as prophages where they silently replicate during cell division (15). Then, either 
spontaneously or in response to external factors such as, DNA-damaging agents or 
antibiotics, prophages can excise and enter into the lytic life cycle to form mature 
phage particles (16). The first step of the lytic cycle involves the circularization of 
the viral genome. Subsequently, the viral genome undergoes several replication 
cycles to generate new phage components and to form long DNA concatemers, 
which are packaged into the phage head (11, 15). The packaging is mediated by 
a phage terminase enzyme, which recognizes a phage-specific packaging site and 
cleaves the DNA creating a free end to which the enzyme remains bound. The 
DNA-terminase complex is directed to the phage head to initiate DNA packaging. 
Once the packaging is completed, the terminase makes another cut in the DNA to 
dissociate it from the phage head. The enzyme remains bound to the concatemer 
end and begins a new round of DNA packaging into another empty capsid. Finally, 
mature phage particles are able to lyse the host and infect new bacterial cells (17). 
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Occasionally, some parts of the host bacterial genome can also be transferred 
during transduction, either by generalized or specialized transduction. In gener-
alized transduction, the phage packages and transfers any portion of bacterial 
DNA. This happens due to mistakes by the terminase, which wrongly recognizes 
packaging sites in the host bacterial genome and mediates its packaging (15). 
This mechanism was originally discovered in Salmonella phage P22 and together 
with phage P1 of E. coli; they represent two well-studied models of generalized 
transduction (18, 19). In contrast, during specialized transduction only a specific 
set of genes is transferred. Studies of the E. coli λ phage have shown that the 
abnormal prophage excision brings adjacent segments of the host bacterial DNA 
together. The lytic cycle proceeds naturally resulting in a hybrid molecule which is 
recognized by the terminase, packaged and transferred to new bacterial cells (20). 
Recently, a third type of transduction, named lateral transduction, has been 
identified in Staphylococcus aureus phages (21). This transduction mechanism 
also involves the transfer of bacterial chromosomal DNA but unlike the afore-
mentioned mechanisms, this process appears to be programmed and not the 
result of an erroneous process. Importantly, staphylococcal prophages do not 
follow a typical lytic cycle as they excise late in their life cycle. As a consequence, 
the terminase initiates DNA packaging in situ from integrated prophages. This 
results in the transfer of large spans of bacterial chromosomal DNA adjacent to 
prophages at much higher frequencies than genes located elsewhere (21). Thus, 
it has been reasoned that transduction is not only a major mechanism to spread 
virulence factors, but also an evolutionary adaptation to ensure phage survival 
and to increase its host´s fitness (22). 
1.1.3 Natural Transformation
Natural transformation refers to the process by which free DNA from the environ-
ment can be actively taken up by bacteria. The extracellular DNA used as substrate 
for transformation can be secreted into the environment by other bacteria or 
released by dying bacteria. Notably, extracellular DNA is also a major component of 
biofilms formed by many pathogenic bacteria (23, 24). The stability of the extracel-
lular DNA in the environment will dictate the bacterial transformation efficiency. 
To date, about 80 bacterial species have been identified that can undergo natu-
ral transformation, including representatives of both Gram-negative and Gram-
positive bacteria as well as cyanobacteria and archaea (25). All transformable 
bacteria are thought to share common, conserved mechanisms to assemble 
surface located structures called pili that are required for DNA uptake. The only 
known exception is Helicobacter pylori which uses a conjugation-like system for 
DNA transport (26).
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Natural transformation is exclusively mediated by the recipient bacteria and all 
required proteins are encoded in the core genome (25). Transformation is a step-
wise, energy-requiring process and involves the following stages: (i) binding of 
double-strand DNA to the bacterial cell, (ii) processing of DNA and transport into 
the cytoplasm and (iii) recombination and integration of the transforming DNA into 
the bacterial genome (27). Thus, natural transformation requires a coordinated 
expression of multiple proteins to ensure efficient DNA uptake. This is achieved 
through a highly regulated process during which bacteria first need to become 
competent. During this distinct physiological state, all the proteins required for 
DNA uptake, processing and recombination are produced. Depending on the 
species, the competence window varies but is typically time-limited in response 
to distinct environmental cues such as cell density, nutrient availability or stress 
conditions. For instance, in Haemophilus influenzae, competence is induced in 
vitro in response to a nutrient downshift or signals of starvation (28). In other 
bacteria, like Legionella pneumophila, competence is induced in response to DNA 
damaging agents or UV radiation (29). The formation of biofilms also seems to 
stimulate the rate of transformation in some human pathogenic bacteria such 
as Campylobacter jejuni and Streptococcus mutans (30, 31). In addition, some 
bacteria synchronize their competence state with other physiological responses 
including growth arrest or bacterial competition. In Bacillus subtilis, competence 
is induced at high cell density or in the beginning of the stationary phase and 
only 10-20% of the bacteria in the culture are becoming competent (32). In addi-
tion, competence induction in B. subtilis leads to cell growth arrest which can 
last several hours once cultures are diluted into fresh medium (33). Bacteria in 
this bistable state are also more tolerant to different antibiotics like penicillin, 
kanamycin and oxolinic acid, a quinolone-type antibiotic (33, 34). In nature, it is 
plausible that this long cell growth arrest could function as a mechanism to ensure 
proper chromosome maintenance after transformation and to survive in complex 
environments like soil (27). Among other transformable bacteria, S. pneumoniae 
was also shown to undergo growth arrest upon induction of competence in vitro. 
This was proposed to help pneumococci to maintain their genomic integrity during 
transformation without compromising cell viability (35). In contrast to B. subtilis, 
competence in S. pneumoniae is induced early during exponential growth and, 
in laboratory strains including D39, more than 95% of the culture can become 
naturally competent (36). 
Different theories regarding the costs and benefits of natural competence for 
transformation have been proposed including that competence functions as 
repair mechanism or as an adaptation strategy to new environments through 
the acquisition of new traits (37). These hypotheses are not mutually exclusive 
and the reason to become competent is likely bacteria-dependent in response 
to the challenges of the surrounding environment. 
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1.1.4 HGT and the spread of antibiotic resistance 
Antibiotic resistance is an emerging major global health threat as antibiotics are 
losing effectiveness against an increasing number of bacterial pathogens. It is esti-
mated that worldwide at least 700 000 people die annually due to drug-resistant 
diseases (38). With the burden of antibiotic resistance increasing globally, it was 
predicted that this number will increase up to 10 million deaths annually by the 
year 2050 (39).
Resistant bacteria can rise and spread through selective pressure created by anti-
biotics favouring resistance or alternatively, antibiotics eliminate susceptible bac-
teria allowing resistant bacteria to propagate (40). They often represent a major 
concern in healthcare centres and hospital settings and their rise in community-
acquired infections is alarming (41). HGT plays a central role in the rapid spread of 
resistance since bacteria easily exchange genetic material and transfer antibiotic 
resistance genes (ARGs) to multiple related or unrelated species leading to seri-
ous infections and outbreaks (40, 42). Considering the three main mechanisms 
of HGT, conjugation is often viewed as the main mechanism responsible for the 
spread of antibiotic resistance associated with hospital-acquired infections. The 
reason for that is related to the high occurrence of plasmids carrying ARGs that 
can be promiscuously transferred to a wide range of recipient bacteria (42-44).
Plasmid-mediated resistance to β-lactam antibiotics exemplifies how ARGs have 
been disseminated by intra- and interspecies conjugation (45, 46). Resistance 
to β-lactam antibiotics can be acquired by the action of extended-spectrum 
β-lactamases (ESBLs) and carbapenemases which hydrolyse β-lactam antibiotics 
like penicillin and carbapenem (47). The development of carbapenem resistance 
has become a public health threat since carbapenems are among the antimicrobials 
considered as last-line antibiotics. This type of antimicrobial resistance has been 
observed in clinically relevant carbapenememase-producing Enterobacteriaceae 
such as E. coli, Klebsiella spp., and Enterobacter spp. (48). In 1996, carbapenemase-
resistant K. pneumoniae (KPC) were first reported in the USA and a number of 
plasmids carrying KPCs have been described that can be transferred by HGT (45, 
49-51). The alarming rate of carbapenem resistance spreading is of major concern 
and has resulted in outbreaks worldwide. In Europe, its prevalence is high mainly in 
southern and eastern countries whereas it still remains low in northern ones (52). 
Another example where HGT, namely conjugation, is implicated in the spread 
of antibiotic resistance and virulence determinants is the pathogen S. aureus, 
which is a major cause of nosocomial and community-associated infections (53). 
The treatment of infections caused by this pathogen is being challenged by the 
development of resistance to β-lactam antibiotics through the acquisition of the 
mec gene, which encodes a low-affinity penicillin-binding protein and confers 
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resistance to methicillin and most β-lactam antibiotics (54). The methicillin resist-
ance gene is often plasmid-encoded, hence can be easily transferred by HGT. 
As a consequence, methicillin-resistant S. aureus (MRSA) has become a major 
healthcare burden worldwide. The prevalence of MRSA infections in Europe is 
somewhat similar to what has been described for carbapenem resistance above, 
with southern countries having a higher prevalence compared to northern coun-
tries (55). Vancomycin is frequently used to treat MRSA infections and although 
still sporadically, clinical isolates of vancomycin-resistant S. aureus (VRSA) have 
been identified (56). VRSA has evolved from MRSA by acquisition of a plasmid 
containing vancomycin resistance genes from Enterococcus faecalis likely by 
conjugation (57). Taken together, these examples show that conjugation plays a 
major role in the occurrence and spread of antibiotic resistance, however, the 
impact of transduction and natural transformation should not be disregarded. 
Phages are often pointed out as an alternative approach to antibiotics in the fight 
of multi-drug resistance, and phage therapy has been successfully used to treat 
infections caused by many pathogens including S. aureus, E. coli and Streptococcus 
spp. (58, 59) However, it should not be ignored that many of these pathogens 
carry phages that could potentially transfer genetic material. Although a direct 
evidence that transduction can occur in clinical settings is currently lacking, in vitro 
transduction of phages in Enterococcus, Pseudomonas and Staphylococcus spp 
has been observed (42). In laboratory conditions, the majority of bacterial spe-
cies tested presented relatively low transduction frequencies of phages carrying a 
particular ARG (10-5-10-9 transductants/plaque-forming unit (pfu)). However, in S. 
aureus a phage carrying a streptomycin resistance gene was able to transduce at 
a much higher frequency (10-1 transductants/pfu), suggesting that these phages 
could contribute to the spread of antibiotic resistance (60). 
The limited number of known natural transformable bacteria identified to date 
may underestimate the importance of transformation in the development and 
spread of antibiotic resistance. According to the World Health Organization (WHO) 
priority list of antibiotic resistant bacteria, which includes 12 bacterial species, 8 
of those are known to be naturally transformable (42).  For example, in multi-drug 
resistant Neisseria gonorrhoeae, which are increasingly more difficult to treat, it 
is believed that the majority of gonococcal ARGs have been acquired by natural 
transformation (61). Interestingly, many of the species present on the WHO list, 
such as A. baumannii and P. aeruginosa, live in communities and can form biofilms 
that contain extracellular DNA as their major component.  
In summary, conjugation is considered as the primary mechanism responsible for 
antibiotic resistance. However, the impact of transduction and natural transfor-
mation cannot be underestimated. 
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1.2 Bacterial pili: an overview
Bacteria express distinct non-flagellar, filamentous structures termed pili or fim-
briae protruding from their surfaces. Bacterial pili were first discovered in Gram-
negative bacteria in the late 1940s and since then they have been extensively 
studied in association to different diseases (62, 63). Two decades later, pili were 
also identified in Gram-positive bacteria, and today it is also known that pili are 
widely present among these bacteria (64-66). Different types of pili can be distin-
guished based on their morphology and assembly pathways, including chaperone-
usher pili, curli, type IV pili, conjugative pili, type V pili and sortase-mediated pili 
(Figure 1 and Figure 2). They can display a wide range of functions, such as adhe-
sion to host cells, biofilm formation, twitching motility, and exchange of genetic 
material, being important for virulence of many pathogenic bacteria (63, 65). In 
this section, a summary of the structure, function and assembly mechanism of 
different pilus systems will be presented. 
Chaperone-usher (CU) pili are ubiquitously present on the surface of many 
Gram-negative pathogenic bacteria (67). CU pili are multi-subunit polymers 
non-covalently linked that require two accessory proteins for their assembly in 
the outer membrane: a periplasmic chaperone protein and an outer-membrane 
pore-forming protein named the usher. The chaperone facilitates the correct 
folding of pilin proteins and presents them to the usher. At the usher, pilins are 
assembled and the growing pilus is translocated to the bacterial surface through 
the usher pore (68). CU pili can be up to 3 µm long and in many species, they are 
composed of thousands of pilus subunits forming a thick helical rod connected 
to a thin fibrillar tip (fibrillum) formed by distinct subunits. However, this archi-
tecture is not conserved in all CU pili as some lack the tip fibrillum while others 
lack the rod structure (68). 
CU pili have been extensively studied in the context of urinary tract infections 
(UTI) caused by uropathogenic E. coli (UPEC). These bacteria assemble two types 
of CU pili, type 1 and P pili, which will be used here as CU pili models. Components 
of type I and P pili are encoded in the fim and pap operons, respectively (69). 
Both type 1 and P pili form a short, thin tip fibrillum assembled on a thicker heli-
cal rod, 1-3 μm in length. They differ in the number of pilus components, which 
form the tip fibrillum. In type I pili, the tip fibrillum consists of one copy of FimG 
and FimF pilus subunits. FimF connects the fibrillar tip to the pilus rod which is 
composed of more than thousand copies of the pilus subunit (FimA). P pili pre-
sent a similar architecture but have longer tip fibrillae. The fibrillar tip is formed 
by an individual copy of PapF together with 5-10 copies of PapE. In addition, one 
copy of the PapK subunit links the tip fibrillum to the rod. The rod is composed 
of multiple copies of the main subunit (PapA) (63, 69). At the distal end of the 
fibrillar tip, both type 1 and P pili present an adhesin protein (FimH and PapG, 
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respectively), which interacts with distinct host-cell receptors. FimH interacts 
with D-mannosylated receptors on bladder epithelial cells, whereas PapG binds 
to galabiose (Galα1-4Gal)-containing glycosphingolipids present on the kidney 
epithelium (70, 71). Thus, type 1 pili are involved in the adhesion to the blad-
der, whereas P pili target the kidney. Together, they play an important role in the 
development of UTIs allowing the bacteria to translocate from the bladder to the 
upper urinary tract (68, 72). For this reason, CU pili have been considered attrac-
tive antibacterial targets to prevent UTIs. Mannosides, mannose derivatives, which 
compete with the cognate receptor of the FimH adhesin, have been developed 
and shown promising results in treating chronic UTIs in murine models (73, 74).
Curli are coiled fibres assembled by many enteric bacteria. They are involved in 
different functions including host cell adhesion, invasion and biofilm formation 
(75). Curli can be up to several micrometres long and resemble amyloid fibres. 
Historically, amyloid fibres are formed by unfolded or misfolded proteins that 
are prone to aggregate and represent pathological hallmarks of some neurode-
generative diseases such as Alzheimer’s and Parkinson’s (76). However, amyloid 
fibre formation can also be the result of a functional biogenesis system compris-
ing properly folded proteins. Curli are an example of a such system, which is why 
they are considered as functional amyloid fibres (75). 
Curli formation is well-studied in E. coli and Salmonella spp. (77). In E. coli, pro-
teins involved in curli formation are encoded in the csgBAC and csgDEFG operons 
(78). Curli are composed of two components non-covalently linked: the major 
structural subunit CsgA (also named curlin) and the pilus assembly nucleator 
CsgB. Curli assembly must be highly controlled to avoid the toxicity found in 
disease-associated amyloid fibres and incorrect curli assembly could lead to the 
disruption of bacterial membrane integrity (79). CsgD is the main regulator that 
coordinates curli biogenesis. To protect bacteria from the toxicity associated with 
an accidental periplasmic accumulation of curli subunits, the periplasmic protein 
CsgC interacts with CsgA to prevent premature fibre formation (80). Two acces-
sory proteins named CsgE and CsgF mediate the secretion and assembly of curli 
trough the transport channel formed by CsgG (81). 
Curli are resistant to proteolytic degradation and distinct physiological conditions 
including osmolarity and pH variations. In E. coli, it was shown that CsgA subunits 
fibrillate in vitro over a wide range of pH values and salt concentrations (79). The 
ability of CsgA to form fibrils in a large number of conditions may facilitate the 
adaptation of E. coli to different environments.  
The crosstalk between bacteria can also mediate curli assembly. Evidence of such 
collaboration has been shown in vitro by growing an E. coli strain lacking csgB 
but expressing csgA in close proximity to another E. coli strain encoding csgB but 
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lacking csgA. Interestingly, the soluble CsgA subunits polymerized and formed 
functional curli on the surface of the strain only expressing CsgB (81), a process 
known as interbacterial complementation. Interbacterial complementation has 
also been observed in multispecies biofilms formed by E. coli and S. typhimurium. 
These bacteria can share curli subunits between them to assemble functional 
fibres thereby restoring bacterial adhesion in multispecies biofilm communities 
(82). In nature, E. coli and Salmonella spp. often coexist in the same niche, thus it 
is plausible that they collaborate mutually to adhere better and form more resist-
ant biofilms providing fitness advantages and better survival options. 
Type IV pili (T4P) are filaments which can be several micrometres in length. They 
are widespread among Gram-negative and Gram-positive bacteria as well as in 
archaea (63, 65). In the latter, these filaments are named the archaeal flagellum 
or ‘archaellum’ (83). T4P have been implicated in several functions including 
adhesion, cell aggregation and biofilm formation, bacterial motility, DNA uptake 
and electron transfer (65). A comprehensive description of the major T4P com-
ponents, their assembly and functions will be presented in detail later. 
Conjugative pili are commonly found in both Gram-negative and Gram-positive 
bacteria (84). These tube-like filaments play a crucial role in bacterial conjugation 
by mediating cell-cell contact and the exchange of genetic material. Conjugative 
pili can be several micrometres long and their assembly, extension and retraction 
requires multiprotein nanomachines called type IV secretion systems (3, 85). Two 
well-known T4SSs are the F plasmid transfer system in E. coli and the Ti plasmid 
injection system in plant pathogen A. tumefaciens (86). The nomenclature from 
A. tumefaciens is often used to describe these systems and it will be used herein. 
The components of the Ti plasmid injection system are encoded in two operons, 
virB and virD. The virB operon encodes 11 structural components (VirB1-VirB11) 
and the virD operon encodes four regulatory and accessory proteins (VirD1-VirD4) 
(87). The T4SS in A. tumefaciens is formed by a transmembrane secretion complex 
composed of three ATPases (VirB4, VirD4 and VirB11), structural components 
(VirB3, VirB6 and VirB8 that form a complex in the inner membrane and VirB7, 
VirB9 and VirB10 that form a complex in the outer membrane) and the pilus 
made of the major pilin subunit VirB2 and a minor subunit (VirB5). In addition, a 
hydrolase (VirB1) breaks down the peptidoglycan layer thereby facilitating T4SS 
formation (87). A. tumefaciens uses its conjugative pili to inject DNA into plant 
cells, which leads to the formation of plant tumours (13). 
Significant progress in deciphering the structural organization of T4SSs has emerged 
from studies of the F plasmid transfer system encoded by the tra operon in E. coli. 
Cryo-electron microscopy studies of two members of the F pilus family originated 
in an atomic model where the major pilus subunit TraA is polymerized in a five-
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start helical filament (88). Interestingly, the authors also found that pilin subunits 
form a stoichiometric protein-phospholipid unit in a 1:1 ratio (88). It was there-
fore proposed that the incorporation of phospholipids into the filament helps 
the exchange of DNA during conjugation by making the pilus lumen moderately 
electronegative. It was further suggested that the presence of phospholipids 
reduces the energetic barrier for pilus assembly enabling an efficient cargo deliv-
ery into the recipient bacterium (88). Recently, unprecedented F pilus-associated 
structures in the native bacterial cell envelope were identified by in situ cryo-
electron tomography (ET) (89). Four distinct structures were identified: the T4SS 
composed of the outer and inner membrane complexes connected by a central 
channel with (i) or without (ii) pilus visible at the outer membrane. In addition, 
two novel structures were visualized, (iii) one containing the F-pilus attached only 
to a thin capped stalk spanning the periplasm and (iv) one where the F-pilus was 
associated with the outer membrane without any visible periplasmic structures 
associated. Based on these results, it was then proposed that the structures (i) 
and (ii) were involved in conjugation and plasmid transfer while the two novel 
structures (iii) and (iv) are likely to facilitate bacterial aggregation. Altogether, is 
believed that coordinated assembly of these different structures would increase 
the probability of plasmid transfer (89). 
Type V pili were first characterized in 2016 in the human oral pathogen 
Porphyromonas gingivalis, the causative agent of severe adult periodontitis and 
gingivitis (90). They are formed by a divergent set of proteins found particularly 
in the class Bacteroidia, which is why these pili are also known as Bacteroidia  pili 
(90). Bacteroidia pili play an important role in virulence contributing to bacterial 
adhesion and biofilm formation (91, 92). P. gingivalis assembles two morpho-
logically distinct type V pili: long (0.3-1.6 µm ) or short (80-120 nm) pili (93, 94). 
Both pili are encoded in similar operons by genes coding for the structural pilin 
that forms the pilus stalk, anchoring pilins which connect the pilus to the bacte-
rial membrane, minor subunits including the tip pilin and additional regulatory 
proteins (95, 96). The current understanding is that these pili are synthesized 
using a lipoprotein-proteinase pathway (90). Pilus subunits are translocated as 
lipoprotein precursors to the periplasmic side of the inner membrane where the 
precursors are lipidated and are cleaved by a signal peptidase. Then, modified 
pilins are transported across the outer membrane through an unknown pore 
with the help of a chaperone-like lipoprotein, which likely recognizes the lipid 
moiety in the pilus subunit. After secretion, stalk pilin subunits, and tip pilins, but 
not anchor pilins, undergo a second proteolytic cleavage to remove the lipidated 
fragment prior to pilus assembly. Further studies are required to understand the 
exact pilus assembly mechanism. Interestingly, the use of extracellular peptides 
that target the major pilus subunit leads to disruption of pilus polymerization and 
hence reduce the ability of P. gingivalis to form biofilms, indicating a promising 
strategy for treatment and/or prevention of periodontal diseases (91).  
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Sortase-mediated pili are exclusively found in Gram-positive bacteria. These bac-
teria lack the outer-membrane present in Gram-negative bacteria, which is why 
they require a distinct mechanism for pilus assembly and attachment to the bacte-
rial surface. The assembly of sortase-mediated pili relies on the transpeptidation 
activity of enzymes named sortases (97). Sortases are cell surface-associated or 
anchored transpeptidases, which recognize a conserved C-terminal LPXTG motif 
in the substrates and mediate their attachment to the peptidoglycan or covalently 
link pilin proteins to assemble pili. Among the six sortase classes (A, B, C, D, E, and 
F), class C sortases are responsible to covalently link pilus subunits into polymers 
whereas others have cell wall anchoring functions (98). 
Sortase-mediated pili were first identified in 1968 in the animal pathogen 
Corynebacterium renale (64). Later, it was shown that these pili are present in 
many other Gram-positive bacteria including Streptococcus and Enterococcus 
spp., where they play an important role in host-cell adhesion and biofilm forma-
tion (97). Two types of sortase-mediated pili have been described: short and thin 
structures which can be up to 500 nm in length and longer flexible pili which can 
be up to 3 µm long (99). A typical sortase-mediated pilus is composed of three 
building blocks: the basal pilin responsible for anchoring of the pilus to the pepti-
dogylcan, the backbone pilin and the tip pilin with adhesive properties. These pilus 
components are encoded in genes clustered together with genes encoding pilus-
specific sortases (97). Pilus-specific sortases initiate pilus assembly by cleaving the 
LPxTG motif of the tip pilin, which is then covalently linked to the backbone pilin. 
The backbone pilin is also recognized and cleaved by a dedicated sortase, which 
catalyses the linkage between backbone pilins promoting pilus polymerization. 
The polymerization is completed when the basal pilin is added to the pilus, which 
together with a dedicated sortase functions as the termination signal. The pilus 
backbone is then covalently linked to the basal pilin, which anchors the entire 
structure to the peptidoglycan. The adhesive properties of these filaments are 
important in the pathogenesis of several Streptococcus species. For this reason, 
pili have been attractive targets for vaccine development to combat infections 
caused by these Gram-positive pathogens. For instance, the crystal structure of 
the backbone pilin in Group B Streptococcus revealed that most of the protec-
tive epitopes are localized in a single domain. This information could help in the 
development of a pilus-based vaccine against Group B streptococcal infections 
which still represent a serious threat to new-borns (100, 101).
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Figure 1. General organization of chaperone-usher pili, curli, conjugative pili and type V pili in Gram-
negative bacteria and sortase-mediated pili in Gram-positive bacteria. OM – outer membrane, PG 
– peptidoglycan, IM – inner membrane. Question mark (?) represents unknown proteins or steps 
during pilus formation. 
Taken together, pili are widespread bacterial surface structures that represent 
crucial virulence factors for many pathogenic bacteria. Research in the field of 
microbial pathogenesis has particularly focused on understanding the different 
type of pili and their associated functions. Interestingly, different types of pili 
share the same pilus associated function, such as adhesion or biofilm formation, 
which represent a common strategy used by different pathogens to colonize and 
cause disease in various niches. Moreover, recent structural investigations of these 
bacterial systems have unquestionably provided additional valuable information. 
Thus, the continuous development of higher-resolution techniques will be of great 
importance to further understand the complexity of these structures, which will 
help to develop novel antimicrobial strategies that target key pilus components.
1.3 Type IV pili: a closer look
T4P were initially described in P. aeruginosa and subsequently identified in many 
other Gram-negative human pathogens including Neisseria spp. (102). Due to 
their architectural characteristics, that involve crossing both the inner and outer 
bacterial membranes, they were initially thought to be present only in Gram-
negative bacteria. However, later reports also demonstrated their existence in 
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Gram-positive bacteria as well as in archaea (65). T4P can be several microns in 
length and have been observed as individual structures or in bundles depending 
on the species (65, 103). These structures are also remarkably  flexible being able 
to bear stress forces greater than 100 pN (104). T4P are predominantly composed 
of numerous copies of a single protein called major pilin. In addition, minor pilin 
proteins, which are present at lower abundance, can also be incorporated into 
the filament (65, 105). 
1.3.1 Type IV pili biogenesis: key components 
T4P assembly requires sophisticated machineries composed of distinct multipro-
tein complexes which can involve up to 15 or more proteins depending on the 
species (106). In Gram-negative bacteria, the T4P machinery spans both inner 
and outer membrane and shares homology with the type 2 secretion system 
(T2SS), which is involved in the translocation of proteins from the periplasm to the 
outer membrane (103). Recent advances in genomic sequencing and structural 
biology started to provide a better understanding of T4P systems also in Gram-
positive bacteria and revealed that they share remarkable similarities with T4P 
systems in Gram-negative bacteria. T4P biogenesis has been extensively studied 
in Gram-negative bacteria, where T4P were first identified. In this section, a gen-
eral overview of the main components involved in pilus assembly with focus on 
T4P in Gram-negative bacteria will be presented. 
1.3.1.1 Pilins
Pilins, in particular the major pilin, are the primary components of T4P. In addi-
tion, minor pilins present in lower abundance can also be part of the filament 
(107). Pilin proteins are synthesized as precursors referred to as prepilins. Prepilins 
share a hydrophilic leader peptide (signal peptide) typically ending with a glycine 
residue, which is recognized and cleaved by a unique leader peptidase (prepilin 
peptidase). All pilin proteins also share a conserved hydrophobic N-terminal 
domain, which allows them to be anchored in the inner membrane, with the signal 
peptide facing the cytoplasm and the C-terminal domain facing the periplasm. 
The C-terminal domain is highly variable among pilins, and it is associated with 
the functional diversity of T4P (108).
Conventionally, T4P pilins can be divided into two classes, type IVa and IVb, 
based on the length of their N-terminal signal peptide. Type IVa pilins possess 
short signal peptides (with less than 10 residues) and result in the assembly of 
thinner filaments, whereas type IVb pilins have longer signal peptides that can 
range from 15 to 30 residues. The first residue of the mature protein is typically 
a phenylalanine for type IVa pilins and another hydrophobic residue for type IVb 
pilins (e.g. methionine, leucine or valine). Type IVa prepilins exhibit considerable 
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sequence homology in their N-terminal hydrophobic domain when compared to 
their type IVb counterparts (106, 107). T4P composed of type IVa pilins can be 
found in plant, animal and human pathogens including Pseudomonas, Neisseria, 
and Dichelobacter as well as in environmental genera such as Thermus, Myxococcus 
and Deinococcus. Pili formed by type IVb pilins are more diverse and have been 
divided in different sub-families. Pilins belonging to the class of type IVb have 
been characterized in enteric bacteria such as enterotoxigenic E. coli (ETEC), enter-
opathogenic E. coli (EPEC), S. enterica serovar Typhi and Vibrio cholerae (107).
1.3.1.2 Prepilin peptidase
A crucial step of T4P assembly is the cleavage and processing of prepilins into 
mature pilins prior to their oligomerization into pili. This requires the proteolytic 
activity of a family of dedicated proteases called type IV prepilin peptidases. The 
first prepilin peptidase was described in P. aeruginosa and is encoded by the 
gene pilD (109). Later, PilD-like prepilin peptidases have been identified in both 
Gram-negative and Gram-positive bacteria. In Gram-negative bacteria, PilD is 
located on the cytoplasmic side of the inner membrane (110). Prepilin peptidases 
are typically composed of two domains: one peptidase domain which removes 
the hydrophilic signal peptide present in type IV prepilins and a second domain 
responsible for N-methylation of the first residue of mature pilins (111). Prepilin 
peptidases recognize and cleave after a conserved glycine or alanine which is fol-
lowed by a stretch of primarily hydrophobic residues present in the signal peptide 
(109). Cleavage of the signal peptide, but not pilin methylation, is crucial for the 
assembly of functional pili (112-114).
1.3.1.3 Assembly/retraction ATPases and platform protein
Besides major and minor pilin proteins, all T4P systems also encode a conserved 
integral membrane protein and assembly and retraction ATPases. The integral 
membrane protein is believed to function as an assembly platform where pilus 
assembly takes place. In P. aeruginosa, the assembly platform was shown to 
interact with the assembly ATPase via its N-terminal cytoplasmic domain (115). 
The action of cytoplasmic ATPases is required to provide the energy to power 
pilus assembly and retraction. When these enzymes bind and hydrolyse ATP, 
conformational changes in the ATPase are induced, which will drive pilus polym-
erization (assembly ATPase) or depolymerization (retraction ATPase). The crystal 
structures of different ATPases revealed that these enzymes form hexameric rings 
(116-118). How exactly ATP is used to drive pilus polymerization is still not clearly 
understood. However, two main models have been proposed: (i) a rotation model 
and (ii) a compression model. The rotation model is based on the structure of 
the assembly ATPase present in Geobacter metallireducens and cryo-ET imag-
ing of the T4P machinery of M. xanthus (119, 120). In this model, ATP hydrolysis 
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leads to conformational changes in the assembly ATPase, which are transferred 
to the platform protein and induces its rotation. This movement forces the pilus 
subunits out of the membrane and opens a gap around the base of the filament 
that will allow the docking of the next incoming pilus subunit (118-120). In G. 
metallireducens it was suggested that the cytoplasmic domains of the platform 
protein are inserted into the lumen of the assembly ATPase and the transmem-
brane domains are located underneath the growing fibre. Alternatively, cryo-ET 
analysis of the M. xanthus T4P machine proposed that the cytoplasmic domains 
of the platform protein are not part of the lumen of the assembly ATPase but 
instead associated with the top (120). In both cases, the resulting energy from ATP 
hydrolysis is transferred to the platform protein causing its rotation to promote 
assembly of the pilin subunits into T4P (119). 
The compression model proposes that the platform protein forms a ring and func-
tions as a gate that opens and closes to control pilin assembly or disassembly. In 
this model, ATP binding and hydrolysis leads to closing of the gate and in order 
to release the compression force generated, subunits of the growing filament 
are pushed outwards allowing the platform protein to return to its relaxed state 
for the docking of the next subunit (121). Thus, this model does not consider a 
rotation of the platform protein but only conformational changes in the protein 
itself (121). Conceptually, it represents a simpler model and further studies are 
needed to support and validate this model.
In both rotation and compression model, the retraction ATPase activity results in 
opposing motions that will drive the pilus depolymerization back into the mem-
brane (118-121).  While assembly ATPases are intrinsically present in T4P, only 
some T4P systems employ retraction ATPases that lead to pilus depolymerization. 
For instance, retraction ATPases have been well documented in P. aeruginosa and 
Neisseria spp. in which the major retraction motor is PilT. Interestingly, both sys-
tems possess additional retraction ATPases, one (PilU) in P. aeruginosa and two 
(PilU and PilT2) in Neisseria spp. (122, 123), which complement the function of 
PilT. In both, Neisseria and Pseudomonas deletion of the main retraction ATPase 
results in loss of pilus associated functions, such as DNA uptake or twitching 
motility (124-126). However, in N. gonorrhoeae retraction was still observed in 
the absence of all three retraction motors, although at much lower speed, (127). 
These observations suggest that gonococcal T4P retraction can occur spontane-
ously, by the action of an unknown protein, or alternatively, by the antagonistic 
action of the assembly ATPase. In fact, Caulobacter crescentus tad T4P lack a 
retraction ATPase but possess a bifunctional ATPase that can power both pilus 
elongation and retraction (128). Similarly, V. cholerae toxin-coregulated pili (TCP) 
are retractile despite lacking a retraction ATPase, and pilus retraction was pro-
posed to be mediated by a single minor pilin (129). 
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1.3.1.4 Secretin subcomplex
In Gram-negative bacteria, pilus assembly occurs in the inner membrane. To reach 
the bacterial surface the filament needs to pass through the outer membrane. 
This is accomplished by the multimeric protein called secretin. The secretin forms 
a pore in the outer membrane through which the pilus can pass (130, 131). In 
many T4P encoding bacteria this pore is formed by the protein PilQ, which is 
well conserved among T4P systems in Gram-negative bacteria (121). Cryo-ET 
studies in T. thermophilus revealed that PilQ is composed of a wide periplasmic 
vestibule with one gate on each side, which are closed in the absence of a pilus 
to maintain the integrity of the outer membrane (132). Thus, the growing pilus 
will trigger conformational changes in the secretin to open the gates and to allow 
the filament to cross the outer membrane. The proper assembly and placement 
of the secretin in the outer membrane is often assisted by an outer membrane 
lipoprotein called pilotin (133). In N. gonorrhoeae and M. xanthus, a third compo-
nent can be found associated with the secretin subcomplex. This protein is called 
secretin-associated protein (TsaP) and is believed to anchor the subcomplex to 
the peptidoglycan (134).
1.3.1.5 Alignment subcomplex proteins
In T4P systems of Gram-negative bacteria, additional proteins are required to 
stabilize and connect the secretin with the ATPase-platform protein complex 
(135, 136). Neisseria and P. aeruginosa T4P systems encode four additional 
membrane-associated proteins (PilM, PilN, PilO and PilP) that collectively form 
an alignment subcomplex, which supports pilus polymerization (121). In T. ther-
mophilus and N. meningitidis, it was suggested that PilM and PilN interact with 
each other, forming a ring on the cytoplasmic side of the inner membrane (137, 
138). PilN further interacts with PilO creating a ring on the periplasmic side of 
the inner membrane. The PilN-PilO complex serves as link between the secretin 
and the ATPase-platform protein complex, thereby directly contributing to both 
pilus assembly and retraction (137, 139). In addition, the PilN-PilO dimer binds 
to the periplasmic inner membrane lipoprotein PilP, which interacts with the 
secretin pore (140, 141). Thus, the PillM-PilN-PilO complex functions both as an 
anchor of the whole alignment subcomplex in the inner membrane and through 
its interaction with PilP aligns the secretin. A similar interaction network among 
the components of the alignment subcomplex has been revealed by cryo-ET of the 
T4P machinery in M. xanthus, suggesting that these interactions are conserved 
among Gram-negative T4P expressing bacteria (120). 
Moreover, in vitro reconstitution experiments in N. meningitidis have recently 
shown that the alignment complex (PilM-PilN-PilO-PilP) together with the assem-
bly ATPase, the platform protein, the major pilin and the prepilin peptidase, form 
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the minimal essential machinery required for pilus assembly in this pathogen. 
According to the authors, this subcomplex is thus a key piece of the assembly 
apparatus rather than just an alignment complex (135). 
Finally, homologues of PilM, PilN and PilO have also been predicted in Gram-
positive bacteria including Clostridium perfringens. However, their role and func-
tion in bacteria lacking an outer membrane is elusive. PilM-PilN-PilO proteins in C. 
perfringens were predicted to have similar membrane topologies as the protein 
homologues in Gram-negative bacteria (65). Thus, it was speculated that these 
proteins are likely to interact with yet unknown partners to form a complex that 
might allow pilus extension through the cell wall. The lack of an outer membrane 
in Gram-positive bacteria might also explain why PilP, which interacts with the 
secretin in Gram-negative bacteria, is absent in these systems (65). 
1.3.2 Type IV pili assembly (and disassembly) mechanism  
Having discussed the individual components required to assemble T4P, the next 
section will describe the details of T4P biogenesis using Neisseria spp. as exam-
ple. Thus, the nomenclature of the pilus components present in Neisseria will 
be used herein. 
The core T4P machinery in Neisseria can be divided into four major subcomplexes: 
(i) the outer membrane secretin subcomplex formed by the secretin PilQ, the 
pilotin PilW and secretin-associated protein TsaP; (ii) the alignment subcomplex 
(PilM, PilN, PilO and PilP); (iii) the motor subcomplex composed of the platform 
protein PilG and the assembly ATPase PilF and the retraction ATPases PilT, PilU 
and PilT2 and finally (iv) the pilus filament itself formed by the major pilin PilE and 
additional minor pilins. The minor pilins include PilH, PilI, PilJ, PilK and PilL, which 
are important for pilus assembly and function, and PilV, PilX and ComP, which are 
dispensable for pilus assembly but crucial for pilus functions (63). Prior to T4P 
formation prepilin subunits are produced in the cytoplasm and secreted via the 
SecYEG pathway into the inner membrane (142). Initially, the prepilins remain 
as bitopic proteins anchored to the inner membrane where they are cleaved by 
the prepilin peptidase PilD (109). Subsequently, mature pilins are recruited to the 
platform protein PilG that is located in the inner membrane and the initiation 
side for pilus assembly. The energy to initiate pilus assembly is provided by the 
ATPase PilF through the platform protein PilG, where pilus polymerization occurs 
(136). Proper fibre elongation is ensured by the PilM-PilN-PilO-PilP subcomplex 
which connects the motor subcomplex and the secretin PilQ through which the 
pilus can cross the outer membrane (141). In N. gonorrhoeae, a pilus tip-located 
adhesin (PilC) is involved in adhesion to host cells (143, 144).  After pilus assembly 
is completed, pilus retraction occurs by the action of the main retraction ATPase 
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PilT, which drives the disassembly of the pilus core (104). The PilT paralogue PilT2 
enhances the speed of pilus retraction by supporting the function of PilT (122, 127). 
Finally, PilU was suggested to modulate the dynamic regulation of T4P-mediated 
microcolony formation and dispersal (145). A schematic representation of pilus 
assembly and retraction mechanism is described in Figure 2.
Figure 2. General organization of type IV pili in Neisseria spp. Adapted and modified from (63, 121). 
OM - outer membrane, PG - peptidoglycan and IM - inner membrane.
1.3.3 Type IV pili-associated functions
T4P are extremely versatile structures, which can mediate a wide range of func-
tions. In this section, a general overview of the most common functions including 
adhesion, microcolony and biofilm formation, twitching motility, DNA uptake as 
well as other functions will be discussed.
1.3.3.1 Adhesion
T4P are common key virulence factors of many pathogenic bacteria as they pro-
mote their adhesion to host cells leading to colonization and establishment of 
severe infections. T4P facilitate adhesion in various ways as opposed to other types 
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of pili, which typically exhibit a single pilus component with intrinsic adhesive 
features at their tip. For gastrointestinal pathogens, such as EPEC and C. difficile, 
it was shown that adhesion can be mediated by the major pilin itself. The major 
pilin of EPEC is called bundlin and functions as adhesin (lectin) with affinity for 
N-acetyllactosamine receptors on human intestinal cells (146). The Gram-positive 
pathogen C. difficile also binds to human intestinal cells via T4P contributing to 
persistence in the host intestine. Interestingly, mutants lacking the major pilin 
PilA1 were able to establish initial colonization but they were outcompeted by 
the WT strain in long-term intestinal colonization in a mouse model (147). These 
examples highlight that T4P-mediated adhesion is a feature shared by both Gram-
negative and Gram-positive bacteria. In fact, expression of the major pilin PilA2 of 
C. perfringes by a N. gonorrhoeae strain lacking its native major pilin PilE resulted 
in the assembly of functional pili, which adhered to mouse myoblast cell lines 
(148). This is an interesting representation of the level of conservation of T4P sys-
tems and its related functions among Gram-negative and Gram-positive bacteria. 
Non-pilin proteins with adhesive properties present at the pilus tip of human 
pathogens like Neisseria spp. or P. aeruginosa have also been implicated in T4P-
mediated adhesion (143, 149, 150). The adhesin PilC in Neisseria spp. plays a 
central role in adhesion to human epithelial cells (144). The functional display of 
PilC in the filaments requires the core minor pilins PIlH-L and the accessory minor 
pilin PilV (105, 124, 151). PilV itself was shown to bind to the immunoglobulin 
superfamily member CD147 mediating adhesion of N. meningitidis to human 
brain or peripheral endothelial cells (152, 153). This leads to the formation of 
membrane protrusions around adhering bacteria thereby increasing their resist-
ance to shear forces created by the blood flow (154). 
1.3.3.2 Microcolony and biofilm formation 
Microcolony and biofilm formation are survival strategies developed by bacte-
ria to adapt and persist in strict environments. The formation of microcolonies 
requires bacterial self-association and represents one of the initial steps in host 
colonization that later often leads to formation of mature biofilms associated with 
chronic infections (155). Microcolony formation is therefore closely associated 
with the ability of many pathogens to adhere to host cells. Thus, like adhesion, 
microcolony formation can be mediated by T4P, namely by pilus subunits like the 
major pilin or minor pilins present in the fibres (156, 157). In N. meningitidis, the 
accessory minor pilin PilX shows intrinsic aggregative properties and promotes 
bacterial auto-aggregation by counteracting the retraction activity of PilT to origi-
nate stable aggregates (157). In addition, Neisseria T4P systems present two PilT 
paralogues (PilT2 and PilU), which support the function of the main retraction 
ATPase PilT. The loss of PilU in N. meningitidis resulted in a delayed microcolony 
formation during infection. Since no major morphological differences were 
20
observed between T4P of the pilU mutant and the WT, PilU seems to be able to 
mediate the proper display of pilus components involved in adhesion (145). In N. 
gonorrhoeae, correct gonococcal microcolony formation after adhesion to host 
cells is influenced by the retraction levels of PilT in which ΔpilT mutants formed 
less microcolonies and were less infective (158). This represents an interesting 
synergy between two T4P-related functions, adhesion and microcolony formation, 
in enhancing both meningococcal and gonococcal pathogenicity.
The ability of T4P to aggregate laterally forming bundles also triggers bacterial 
aggregation and microcolony formation (159, 160). For example, V. cholerae TCP 
self-aggregate through lateral pilus interactions mediated by the major pilin, 
bringing bacteria together to form microcolonies, which protect them from host 
defences (159, 161).
Bacterial microcolonies can develop into mature biofilms to enhance bacterial 
protection against host immune defences and external factors, such as antibiotic 
treatment. Biofilms are crucial in chronic infections caused by P. aeruginosa and 
T4P have been shown to play a key role in both microcolony and biofilm formation 
of this pathogen (162). In the absence of the retraction ATPase PilT, non-retractile 
mutants exhibited irregular biofilm structures indicating that the architecture of 
P. aeruginosa mature biofilms is influenced by T4P-driven bacterial motility (163, 
164). T4P were also shown to be required for microcolony and biofilm formation in 
Gram-positive pathogens such as Clostridia spp. as T4P-deficient mutants formed 
substantially less biofilms than the WT strain (165, 166). 
1.3.3.3 Twitching motility
Twitching motility is a flagellum-independent form of motility adopted by bacteria 
to move over moist surfaces and is commonly observed in bacterial aggregates 
with cell-to-cell interactions (167). Twitching motility allows bacterial communi-
ties to follow stimuli, such as gradients of chemical attractants or nutrient avail-
ability, enabling them to colonize new niches. This type of locomotion is driven 
by the extension, binding, and retraction of T4P located at bacterial poles (121). 
Bacteria extend T4P localized towards the stimulus allowing them to adhere to 
the surface. Then, pili retraction powers twitching motility with the motor force 
generated by pulling pili exceeding the force (≈50pN) required to detach other 
T4P from the surface (168). 
Twitching motility helps human pathogens to move from one site of infection to 
another. For instance, P. aeruginosa mutants lacking the retraction ATPase are 
nonmotile and exhibited reduced virulence associated to the inability to trans-
locate across the corneal epithelium and to disseminate (169). Interestingly, 
a study using microfluidics devices to mimic the biophysical properties of the 
human vasculature, such as shear stresses and flow patterns, revealed that 
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P. aeruginosa uses T4P to move upstream. This likely represents a competitive 
advantage for this pathogen to escape faster-growing bacteria and colonize new 
sites (170). In addition, it was recently reported that intracellular P. aeruginosa 
relies on twitching motility to disseminate throughout the cytoplasm of host 
cells after vacuolar escape, strengthening the role of T4P-mediated motility in P. 
aeruginosa virulence (171).
This type of motility also plays an important role in N. gonorrhoeae pathogenesis 
as motility of gonococcal communities is dependent on coordinated T4P retraction 
to successfully migrate on human epithelial cells (172). Interestingly, the activity 
of PilT2 enhances the twitching speed of gonococcal microcolonies supporting 
the idea that PilT parologues play a role in fine-tuning T4P dynamics (122). 
Gram-positive pathogens, such as S. sanguinis and C. difficile, also use twitching 
motility as form of locomotion, and mutations in the ATPase resulted in non-motile 
aggregates or in aggregates with diminished motility, respectively (173, 174). In 
S. sanguinis, it was further observed that deletion of an uncharacterized gene 
named pilK (with no homology to pilK in Neisseria) resulted in abnormal bacterial 
motility patterns through an yet unknown mechanism (173). 
1.3.3.4 DNA uptake
A subset of bacterial species is competent for natural transformation. Among 
those, some are known to take up DNA from the environment by a preserved 
mechanism involving the assembly of T4P (27). These filaments are assembled in 
the early steps of natural transformation and are essential for DNA uptake (25). 
The exact mechanism through which T4P bind and drive DNA uptake remains 
one of the major questions in the field. This process may vary between species 
and for this reason different models of T4P-mediated DNA uptake have been pro-
posed which includes DNA binding by major pilins or alternatively the presence of 
minor pilins in the filament which can act as DNA receptors (175). Conceptually, 
DNA binding by the major pilin would represent the simplest way considering 
that it is the primary pilus component. However, direct evidence that major pilin 
monomers have DNA binding properties are still lacking. It is important to note 
that while the monomer or recombinant protein does not bind DNA, the proper-
ties of major pilins assembled into pili may differ from the monomers, creating 
a surface that could promote DNA-binding. 
More robust evidence supports the presence of DNA receptors in the filaments 
as explanation for DNA binding. In Neisseria spp., the accessory minor pilin ComP 
has intrinsic DNA-binding ability, recognizing DNA uptake sequences (DUSs), which 
allow bacteria to take up primarily species-specific DNA (176, 177). Among other 
transformable bacteria, H. influenzae also shows a bias to take up DNA by recog-
nizing species-specific sequences called uptake signal sequences (178).
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Recently, live fluorescence microscopy imaging revealed that T4P assembled by 
competent V. cholerae are able to bind DNA presumably through minor pilins 
(VC0858 and VC0859) present at the tip of the pilus (179). DNA binding at the 
pilus tip seems to be compatible with the notion that many T4P retract, bringing 
the DNA to the cell surface where it can be internalized. In fact, blocking pilus 
retraction in N. gonorrhoeae and V. cholerae has a drastic impact on DNA uptake 
resulting in non-transformable bacteria or in very low transformation rates (125, 
179). In both pathogens, T4P retraction is concomitant with the accumulation of a 
periplasmic DNA-binding protein (ComE in Neisseria and ComEA in Vibrio) at the 
site of DNA uptake (179, 180). Compelling observations, using optical tweezers 
in N. gonorrhoeae, support DNA uptake by a translocation ratchet model. In this 
model, pilus retraction brings the DNA to the secretin pore in the outer membrane 
from where the DNA diffuses towards the periplasm where it binds to ComE acting 
as a chaperone (181). How DNA in Gram-positive bacteria is translocated across 
the thick peptidoglycan layer remains an intriguing question. In Gram-negative 
bacteria, the secretin ensures pilus retraction and subsequent DNA translocation 
across the outer membrane, but secretin-homologues forming a similar pore in 
the cell wall of Gram-positive bacteria have not yet been identified.  
1.3.3.5 Other functions 
The extraordinary versatility of T4P goes beyond the most widespread features 
described above. For instance, environmental bacteria belonging to the genus 
Geobacter assemble T4P with conductive properties (182). In these bacteria, 
T4P function as nanowires to transfer electrons involved in the reduction of iron 
oxide minerals and uranium (182, 183). This unusual T4P feature has inspired new 
approaches to engineer novel conductive biomaterials with possible application 
in clinical settings. The development of peptide-based coatings using peptides 
derived from PilA, the major pilin of P. aeruginosa T4P, has shown promising effects 
in preventing corrosion of metallic materials including stainless steels which are 
commonly used in medical devices and implants (184). In addition, adhesion of 
bacteria to stainless steel surfaces coated with these peptides was reduced which 
can be an interesting approach to tackle biofilm formation (185).
Other less common T4P associated functions can be found in cyanobacteria, which 
use T4P to sense and move towards the light in a process called phototaxis. This 
allows them to produce their own “food” via photosynthesis and represents a 
crucial survival mechanism for these bacteria (186). 
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1.4 Type IV pilins: structural insights into the building 
blocks of T4P
In general, pilins are small proteins ranging from 7 to 20 kDa in size. Most type 
IV pilins share a similar domain structure but can differ substantially in size and 
sequence (107). Structurally, the majority of pilin proteins characterized to 
date resemble a “lollipop”, with a globular C-terminal domain and an extended 
N-terminal domain (α1) (Figure 3). Half of the extended N-terminal domain extends 
into the C-terminal domain (α1-C) and the other half (α1-N) protrudes from the 
globular C-terminal domain forming the “lollipop stick” (107, 108). The N-terminal 
domain is highly conserved and formed by a α-helix, whereas the C-terminal 
domain is typically composed of both α-helices and β-sheets (108). The conserved 
α1-N domain acts both as transmembrane domain and as protein-protein interac-
tion domain, anchoring the globular domain in the inner membrane prior to pilus 
assembly. In contrast, the αβ-loop region in the C-terminal end contributes to the 
structural and functional diversity associated with these proteins (187). The α1-N 
region is highly conserved and hydrophobic with the exception of the glutamate 
residue at position 5 (E5) after the prepilin peptidase cleavage site whereas the 
α1-C region is hydrophilic. E5 in mature pilins has been shown to be dispensable 
for processing but important for pilus assembly, as mutants in E5 cannot assemble 
T4P (188, 189). This particular residue was proposed to mediate the docking of 
pilins during pilus polymerization by establishing electrostatic interactions with 
the N-terminus of the last pilin incorporated in the growing pilus (190). Finally, 
many pilins present two disulphide-bonded cysteine residues (D-region), which 
are important for protein stability. In order to assemble T4P, pilins are arranged 
in a helical array with their N-terminal domains forming the pilus core and their 
globular C-terminal domain creating the outer shell of the filament (191). The 
similar architecture between different type IV pilins reinforces the idea that the 
classical fold is conserved among these proteins (107, 108). 
Most T4P are homopolymers formed by one major pilin. Notably, the recent struc-
tural analysis of S. sanguinis T4P revealed that these filaments are composed of 
a 4:3 ratio of two sequence identical major pilins, PilE1 and PilE2. Despite this 
distinct structure, the authors observed that major pilin processing and pilus 
assembly followed conserved mechanisms present in other bacteria (192). 
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Figure 3. Structure of the N. gonorrhoeae major pilin PilE as representative example of a “lollipop-
like” structure. Adapted with permission from Giltner et al., 2012. (107).
1.5 The human pathogen Streptococcus pneumoniae
The first observations of S. pneumoniae, also known as the pneumococcus, date 
to 1881 and are attributed to George Miller Sternberg and Louis Pasteur who 
independently isolated S. pneumoniae from rabbits injected with human saliva 
and from saliva of a rabies-infected child, respectively (193). Pneumococci are 
facultative anaerobic Gram-positive lancet-shaped bacteria, which typically grow 
in pairs as diplococci, but can also occur in single cocci or in short chains. On blood 
agar plates, they form small (1-2 mm) and greyish α-haemolytic colonies (194). 
In addition, pneumococcal colonies can have a mucoid appearance due to the 
presence of a polysaccharide capsule, which coats the pneumococcal surface. To 
date, at least 98 different pneumococcal serotypes have been identified according 
to their capsule structure (195, 196). Three additional phenotypic features allow 
identification of S. pneumoniae. Pneumococci are catalase negative, susceptible 
to optochin and bile soluble (197). Susceptibility to optochin has been broadly 
used as primary test to differentiate pneumococci from other α-haemolytic strep-
tococci (198). However, reports of pneumococcal isolates resistant to optochin 
and of closely related species, including S. mitis and S. pseudopneumoniae, which 
are susceptible to optochin make this test alone not enough to accurately identify 
S. pneumoniae (199-201). Thus, alternative tests including bile solubility, pres-
ence of capsule or PCR techniques targeting genetic loci unique to pneumococci 
should be considered in some cases for the correct identification of S. pneumo-
niae, especially in the clinical setting (199, 202, 203).
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Pneumococci are common colonizers of the human upper respiratory tract, how-
ever, when given the opportunity, they can cause infections, which range from mild 
mucosal infections, including otitis media and sinusitis, to life-threatening infections 
such as pneumonia, sepsis and meningitis (204). Historically, the pneumococcus 
has been a devastating pathogen tightly related to the massive number of deaths 
during the Spanish flu pandemic in 1918-1919. It is estimated that more than 50 
million people died during the pandemic primarily due to co-infections with S. 
pneumoniae (205). Nowadays, pneumococci still represent a risk mainly for children 
under five years old and the elderly but also for immunocompromised persons. 
In 2015, it was estimated that pneumococcal infections were responsible for over 
317 000 deaths globally among children under the age of five (Figure 4) (206).
Figure 4. Global pneumococcal mortality rates and total number of deaths in HIV-negative children 
under the age of five in 2015 (206).
1.5.1 Pneumococcal colonization and disease 
Pneumococcal infections occur through the spread of pneumococci-containing 
droplets or aerosols. However, successful transmission often results in asymp-
tomatic colonization of the nasopharynx and carriage prior to infection. The 
upper respiratory tract therefore serves as a reservoir of pneumococci which is 
especially prevalent in pre-school age children attending day-care centres, with 
carriage rates up to 60% (204, 207). In the adult population, carriage rates are 
much lower (<10%) although higher colonization rates can be found in parents 
of small children (208, 209). 
Pneumococcal disease involves the spread of pneumococci from the nasophar-
ynx to other sites such as the middle ear and sinuses causing otitis media and 
sinusitis, respectively. These pathogens can also gain access to normally sterile 
sites of the body, including the lower respiratory tract, bloodstream or meninges, 
leading to invasive pneumococcal diseases (IPD) (204).
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Acute otitis media (AOM) is an inflammatory disorder affecting the middle ear in 
which it is estimated that by the age of three, up to 80% of the children have been 
affected at least once (210). Although viruses are well-known causing agents of 
otitis media, they predispose individuals to bacterial AOM caused by pneumo-
cocci and other pathogens, including H. influenzae, and Moraxella catarrhalis, 
with S. pneumoniae accounting for 30-50% of AOM cases globally (211-213). 
Recurrent or persistent AOM can lead to more complicated conditions including 
hearing loss or perforation of the tympanic membrane. In Sweden and the USA, 
AOM was reported to be responsible for most of antibiotics prescription among 
children (214). 
Sinusitis is an infection of the sinuses that is caused by viruses and bacteria. 
Bacterial sinusitis is common, and H. influenzae and S. pneumoniae are the 
most common pathogens isolated in paediatric sinusitis. Among those, patients 
infected with pneumococci present a more severe disease than those infected 
with H. influenzae (215). 
The development of IPD during colonization is related to both host susceptibility 
and invasiveness of the pneumococcus (216). S. pneumoniae is the most common 
cause of community-acquired pneumonia (CAP). The 30-day mortality rate due 
to pneumococcal CAP vastly depends on the degree of severity of clinical signs 
but it can be as high as 20% in hospitalized patients (217-219). The distribution 
of pneumococcal CAP cases differs vastly between geographical regions and eco-
nomical standards. In Europe, mortality rates vary from 1-48% depending on the 
country. However, a common denominator is that the mortality is much higher in 
patients ≥65 years of age (220, 221). Predominantly, pneumococcal CAP does not 
result in bacteremia, however, it has been reported that approximately a quar-
ter of pneumococcal CAP cases can lead to septicemia with higher prevalence 
reported among older patients with comorbidities and male patients (222-225). 
Finally, the most severe pneumococcal manifestation is meningitis, an acute 
inflammation of the meninges. Pneumococcal meningitis has high mortality rates, 
with 18-30% of patients dying. Among the survivors, around half suffers severe 
neurological sequelae, including hearing loss and cognitive deficits (226, 227). 
Among the risk groups, children are at greater risk where the global incidence 
rate is estimated to 17 per 100 000 children under the age of five. As for CAP, 
the mortality rate is strongly related with the economic situation of the country 
(228, 229). 
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1.5.2 S. pneumoniae morphology in relation to carriage and 
invasive disease 
Pneumococcal nasopharyngeal colonization is regarded as a prerequisite for the 
development of disease. Colonization of the nasopharynx is a dynamic process 
where interspecies competition can affect or prevent the establishment of pneu-
mococci in the nasopharyngeal flora (230). In addition, colonization requires that 
pneumococci successfully bind to the epithelial cells. Experimental evidence shows 
that the different morphologies adapted by S. pneumoniae can contribute to the 
ability to colonize or lead to invasive disease (231, 232). The ability of pneumococci 
to adhere to epithelial cells in vitro and to colonize in a murine model was shown 
to be related to long-chain forms. By using the clinically relevant encapsulated 
strain TIGR4 as model, it was shown that chain-forming mutants adhered and 
colonized better compared to the WT (232). The morphological heterogeneity 
presented by S. pneumoniae may contribute to its ability to establish as commen-
sal or pathogenic bacteria. Longer chains can facilitate adherence by providing 
a larger contact area with the host cells, whereas the subpopulation of single 
cocci or diplococci could be better to invade due to their smaller size. Consistent 
with this, it was shown that minimizing bacteria length conferred a competitive 
advantage in a systemic infection mouse model (231). 
S. pneumoniae can be killed via opsonophagocytosis by neutrophils. This involves 
opsonization of pneumococci by the complement system and deposition of the 
complement component 3 (C3) which can interact with the complement recep-
tor on neutrophils (233). While shorter chain-forming pneumococci were shown 
to escape killing via opsonophagocytosis, longer chains promoted C3 deposition 
on the bacterial surface and were therefore more susceptible to phagocytosis by 
neutrophils (231). In vivo, mutants with increased chain length were attenuated 
due to complement-dependent clearance. In addition, another study observed the 
presence of only small bacteria size (single cocci) in the brain in a bacteraemia-
derived meningitis mouse model. It was suggested then that the small size of 
single cocci could be beneficial to cross the blood-brain barrier into the brain and 
to cause meningitis (234). Thus, despite the fact that S. pneumoniae characteristi-
cally grows in diplococci, the presence of single cocci and chains may also influ-
ence the ability of various strains to colonize or cause invasive disease (Figure 5).
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Figure 5. Phase-contrast micrograph of S. pneumoniae R6 grown on a blood agar plate overnight 
showing different morphologies. Scale bar 2µm
1.5.3 The pneumococcal capsule 
The vast majority of pneumococcal clinical isolates are encapsulated, however, 
non-encapsulated strains can also be found, either because they have a mutation 
in the capsule (cps) genes or entirely lack the cps locus (235). The virulence of S. 
pneumoniae is mainly attributed to its polysaccharide capsule which surrounds 
the bacterium and protects it from the host immune system. Consequently, the 
capsule has been the target in the development of current pneumococcal vac-
cines (discussed in the next section). The thickness of the capsule varies among 
the 98 different serotypes identified to date and it can be up to 400 nm thick 
in some serotypes (236). In addition, the composition also differs substantially 
among them, which influences the pneumococcal potential to colonize or cause 
invasive disease (237-239). In Stockholm county, a study which characterized the 
effects of pneumococcal conjugated vaccines in carriage and invasive disease, 
observed that the vaccine serotypes 3 and 19A and the non-vaccine serotypes 
22F and 23A showed the greatest increase  among IPD cases after vaccine intro-
duction in the childhood vaccination program, however, serotypes 11A and 35F 
were more prevalent in childhood carriage (240). Most pneumococcal capsular 
serotypes are negatively charged which contributes to the overall surface charge 
(241). The electrostatic repulsion with host immune cells facilitates pneumococci 
to escape from the mucus-mediated clearance and phagocytosis (241, 242). 
Non-encapsulated strains are typically less virulent in mouse models and only in 
rare situations they cause IPD in humans (243-245). However, non-encapsulated 
29
strains in vitro are more prone to acquire genes through natural transformation 
than isogenic encapsulated strains (246). Taking in vitro observations into consid-
eration, non-encapsulated strains have higher transformation frequencies. This 
may indicate that transformation can be facilitated among non-encapsulated 
strains in the nasopharynx in which the lack of capsule also enhances bacterial 
binding to epithelial cells.
1.5.4 Therapeutic options and prevention of pneumococcal 
diseases 
Pneumococcal diseases are still a considerable cause of mortality and bring a 
heavy burden to healthcare systems. The treatment of choice used to tackle 
pneumococcal infections are antibiotics, namely β-lactam antibiotics (e.g. penicil-
lin), macrolides (e.g. erythromycin) and fluoroquinolones (e.g. norfloxacin) (247). 
β-lactams target the bacterial cell wall synthesis by binding to penicillin-binding 
proteins (PBPs). However, mutations in pneumococcal PBPs or in the cell-wall 
muropeptide branching enzyme MurM have been involved in the development 
of pneumococcal resistance to penicillin and other β-lactams (248). The level of 
resistance varies largely between regions with certain areas in Asia reporting 
≥50% of the isolates as being non-susceptible to penicillin (249). In Sweden, an 
official report from 2018 shows that the incidence of S. pneumoniae with reduced 
susceptibility to penicillin was approximately 1 case per 100 000 inhabitants, of 
which most cases (35%) were detected in young children of up to four years of 
age (250). 
Macrolides, such as erythromycin, inhibit protein synthesis through binding to 
the 50S ribosomal subunit. In pneumococci, resistance to macrolides can arise 
by methylation of the macrolide target site by the ermB methylase or by active 
efflux of the drug through an efflux pump encoded by the mefA gene (251). 
Fluoroquinolones, like norfloxacin, are synthetically produced antibiotics, which 
inhibit topoisomerase enzymes (DNA gyrase) thereby promoting breakage of 
double stranded DNA. Pneumococci can develop resistance to fluoroquinolones 
by the action of the efflux pump encoded by pmrA or through mutations in the 
quinolone resistance-determining regions of the subunits of DNA topoisomerase 
IV parC and DNA gyrase gyrA genes (252, 253). Similar to penicillin resistance, 
pneumococcal resistance rates to macrolides and fluroquinolones also differ 
greatly depending on the country. In Sweden, 4.6% of invasive pneumococci 
isolated in 2018 were resistant to erythromycin and only 1.1% were resistant to 
norfloxacin (250).
To target serotypes predominantly associated with IPD cases, prevention plans 
were implemented with the development of pneumococcal vaccines (254). Vaccine 
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efficacy is mediated by the ability to trigger B-lymphocytes to produce protective 
antibodies and immunological memory.  Currently, there are four different pneu-
mococcal vaccines commercialized: the pneumococcal polysaccharide vaccine 
containing 23 capsular polysaccharides (PPSV23) and three pneumococcal con-
jugate vaccines with 7, 10 or 13 capsular polysaccharides conjugated to a carrier 
protein (PCV7, PCV10, PCV13). The list of serotypes covered by each vaccine can 
be found in Table 1. PPSV23 was the first vaccine to be introduced on the market 
in 1983. This vaccine stimulates an antibody production against the pneumococcal 
polysaccharide capsule through a T-lymphocytes independent immune response 
by direct activation of B-lymphocytes (255). The polysaccharide vaccine contrib-
uted to the reduction of IPD cases in adults, but they evoke no or only a weak 
immune response in infants younger than 2 years, one of the principal risk group 
for pneumococcal diseases (256). In young children, the spleen is not entirely 
developed hence B-lymphocytes are not fully matured. As a consequence, they 
do not respond to polysaccharides to evoke an immune response against pneu-
mococci (257-259). There are also observations that the polysaccharide vaccine 
loses efficacy in the elderly as the function of B-cells weakens with age (260, 261). 
Thus, a polysaccharide-conjugated vaccine was developed to surpass the limita-
tions of PPSV23, in particular to induce an immune response in young children. 
In 2000, PCV7 was the first conjugated vaccine to be introduced on the market, 
and PCV10 and PCV13 were licensed in 2010 (262). These vaccines are coupled 
to protein carriers (Table 1) and evoke an antibody response via a T-lymphocyte 
dependent response (263). In this response, B-cells closely interact with T-cells 
in the activation and production of antibodies via the carrier protein (264). PCV 
vaccines have revealed to elicit immune protection in young children as they can 
respond to T-cell dependent antigens. Upon introduction of PCVs in national vac-
cination programs, the number of pneumococcal infections was reduced drasti-
cally. In Sweden, PCVs are included in the childhood vaccination plan since 2007 
and in 2016, 97.1% of children by the age of two year were vaccinated against 
pneumococcal infections (265). As result, a considerable decrease in the numbers 
of IPD cases in vaccinated children was observed (240, 266).  
Vaccination has effectively reduced the nasopharyngeal carriage and IPD rates 
caused by pneumococcal serotypes included in the vaccines. However, serotype 
replacement by serotypes not included in the vaccines has been observed in dif-
ferent reports. This raises the concern that vaccination selects against the sero-
types included in the vaccines, which are then replaced by non-vaccine serotypes 
not included in the PCVs (240, 267, 268). In addition, the rise in colonization and 
infections with non-encapsulated pneumococci should also be seen with cau-
tion. Non-encapsulated strains have been associated with higher transformation 
frequencies in vitro which in biological conditions may facilitate the spread of 
antibiotic resistance and virulence genes (245).
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Table 1. Serotypes covered by the pneumococcal vaccines available on the  market (269, 270).
Vaccine Protein carrier Serotypes covered
PPSV23 (Pneumovax, Merck) None 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 
10A, 11A, 12F, 14, 15B, 17F, 
18C, 19F, 19A, 20, 22F, 23F, 33F
PCV7 (Prevnar®, Pfizer) Non-toxic variant of the diph-
theria toxin
4, 6B, 9V, 14, 18C, 19F, 23F
PCV10 (Synflorix™, GSK 
Biologicals)
Non-typeable H. influenzae
protein D, diphtheria or tetanus 
toxoid
1, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 
19F, 23F
PCV13 (Prevnar™, Pfizer) Non-toxic variant of the diph-
theria toxin
1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 
19A, 19F, 23F
1.5.5 Natural transformation in S. pneumoniae 
Frederick Griffith first described natural transformation in 1928 in S. pneumoniae. 
In a series of elegant experiments, he demonstrated that a non-virulent pneumo-
coccal (non-encapsulated) strain could become virulent when co-inoculated with 
a heat-killed virulent (encapsulated) strain and injected into mice, suggesting that 
a transfer event had occurred between bacteria (271). Later, in 1944, Avery and 
colleagues proved that DNA was the transforming principle (272).
Since its discovery, the transformation process in S. pneumoniae has been exten-
sively studied and can be divided into four steps. First, pneumococci need to 
respond to internal and external cues, which allow them to become competent. 
Once the competent state is activated, competent pneumococci express all the 
genes involved in DNA uptake, integration, and recombination into the genome. 
A subset of these genes encodes proteins required for the formation of the T4P 
and a dedicated DNA uptake machinery named transformasome. Both the T4P 
and the transformasome are fundamental for natural transformation. Third, 
competent pneumococci lyse susceptible non-competent neighbouring bacteria 
by secretion of hydrolases thereby providing the genetic material for transfor-
mation, in a mechanism that is likely simultaneous to pilus formation. Finally, 
transcription of competence genes shuts down leading to the termination of the 
competence period. 
In the following sections, an overview of competence induction and regulation, 
leading to expression of the components involved in DNA uptake, will be described. 
A description of the fratricide mechanism used by competent pneumococci to 
target non-competent siblings and its implications will also be presented. 
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1.5.5.1 Competence induction and regulation 
Pneumococcal competence is induced by a peptide pheromone, named com-
petence-stimulating peptide (CSP), secreted by the bacteria. CSP induction rep-
resents a quorum-sensing signalling that allows bacteria to communicate at an 
intercellular level to monitor and control their own population density. In labo-
ratory conditions, when CSP is externally added to a culture in early exponential 
phase, peak competence is reached 15-20 minutes after induction. Subsequently, 
competence gradually decays to nearly zero in about 40 min (273). During compe-
tence, S. pneumoniae expresses two distinct sets of genes, the early competence 
genes and the late competence genes, which are respectively regulated by ComE 
and ComX. ComE controls the expression of the ABC-transporter ComAB and the 
three-component regulatory system ComCDE crucial in the beginning of compe-
tence induction (Figure 6). CSP, encoded by comC, is synthesized as a precursor 
peptide (ComC), which is processed and secreted by the ComAB transporter (273, 
274). Different CSP types, or pherotypes, have been identified in S. pneumoniae 
and also in other streptococcal species (275). Mature CSP is then sensed by the 
membrane-embedded histidine kinase ComD, which phosphorylates the cognate 
response regulator ComE (276). Phosphorylated ComE (ComE~P) induces the 
expression of the pneumococcal early competence genes, which include comAB, 
comCDE, comX and comM. By promoting the expression of the comAB and com-
CDE operons, ComE~P creates a positive feedback loop that ensures enough 
CSP is produced and thereby allowing a coordinated competence development 
throughout the population (277). ComX is the alternative sigma factor which 
controls the expression of several late competence genes involved in DNA uptake 
and homologous recombination (278). comM endodes the fratricide immunity 
protein which protects competent pneumococci from lysis (see below) (279).
Competence induction can also be triggered by different types of antibiotics, 
such as streptomycin and kanamycin (280). The competence-stimulating effect 
of streptomycin and kanamycin is related to their ability to increase the rate of 
translational decoding errors. In the situation when translation accuracy is high 
the serine protease HtrA supresses competence by degrading CSP. However, when 
translation accuracy is low, HtrA is overloaded with misfolded proteins and is 
not able to degrade CSP, which accumulates and leads to competence induction 
(281, 282). In addition, DNA-damaging antibiotics and compounds like mitomy-
cin C were shown to induce competence by stalling DNA replication elongation, 
leading to an increase in the copy number of genes located close to the origin of 
replication, which include the comAB and comCDE operons. As result, the levels 
of CSP increase and competence is induced (283). Recently, another study found 
that the β-lactam aztreonam and the β-lactamase inhibitor clavulanic acid induce 
competence by targeting the D,D-carboxypeptidase penicillin-binding protein 3 
(PBP3) which phenotypically led to pneumococcal chain formation. This resulted 
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in retaining of CSP on the bacterial surface rather than its diffusion, facilitating the 
local CSP recognition by its membrane-bound receptor ComD. As a consequence, 
competence is not induced simultaneously in the entire bacterial population but 
rather gradually, which results in an overall longer competence period (284).
The shutdown of competence can also occur at multiple levels. The late com-
petence protein, DprA plays an important role in shutting down competence 
by inhibiting ComE-driven transcription whereas the protease HtrA selectively 
degrades ComEA and ComEC, suggesting its participation in the termination 
of pneumococcal transformation by breakdown of the DNA uptake apparatus 
(285-287). A second layer of control to shutdown competence is proposed to 
occur through the competition between the alternative sigma factor ComX (σX) 
and the main sigma factor RpoD (σA) for the interaction with ComW and/or RNA 
polymerase binding by a yet unknown mechanism (288, 289).
Figure 6. Schematic representation of competence induction in S. pneumoniae. Competent pneumo-
cocci synthesize the precursor peptide ComC which is processed into CSP. The ComAB transporter 
secretes mature CSP to the exterior, which is sensed by the histidine kinase ComD. Then, ComD phos-
phorylates the response regulator ComE, which induces the expression of comAB, comCDE, comX 
and comM. ComX regulates the expression of the late competence genes involved in DNA uptake and 
recombination and the fratricide genes. The fratricide immunity protein ComM protects competent 
pneumococci from the proteolytic activity of CbpD. Non-competent pneumococci are lysed by the 
activity of CbpD which activates the activity of LytA and LytC to enhance the lysis during fratricide. 
Lysed pneumococci release DNA that can be used as substrate in natural transformation (290).
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1.5.5.2 Uptake and processing of transforming DNA
Upon competence induction and expression of early competence genes, S. pneu-
moniae expresses several late competence genes encoding the components 
required to form the DNA uptake machinery, also known as the transforma-
some (278). In addition, competent pneumococci assembly a 2-3 μm long pilus 
(discussed in the next section) that facilitates initial double strand DNA (dsDNA) 
binding and then directs it to the membrane-associated DNA receptor, ComEA 
(291). Upon binding to ComEA, the non-transforming DNA strand is degraded by 
the membrane surface endonuclease EndA. Interestingly, EndA is not regulated by 
ComX and is also expressed in non-competent pneumococci where it was shown 
to be involved in virulence by degrading neutrophil extracellular traps (NETs) 
(292). These traps are composed of both DNA and antibacterial proteins and are 
released by activated neutrophils (293). Thus, the degradation of NETs by EndA 
allows the release of captured pneumococci and enables their dissemination 
(292). In non-competent bacteria, EndA is localized uniformly in the membrane, 
however, during competence, EndA is recruited to the midcell by ComEA. This 
strongly indicates that the uptake of DNA takes place at this position in pneumo-
cocci, which coincides with the site of peptidoglycan synthesis (294). The spatial 
coordination between peptidoglycan synthesis and the assembly of the transfor-
masome may facilitate the uptake of DNA through the cell wall. 
The resulting single strand DNA (ssDNA) is then transported into the cytoplasm 
in the 3´ to 5´ direction through the channel formed by the transmembrane 
protein ComEC, with the assistance of other proteins, ComFA and ComFC (294-
296). ComFA binds to ssDNA controlling the uptake rate and has ssDNA-depend-
ent ATPase activity. In addition, it forms a complex with ComFC, which interacts 
with other transformasome components. This places ComFA and ComFC as the 
link between DNA uptake and DNA recombination during transformation (296).
Upon entry into the cytoplasm, ssDNA fragments are coated by the single-stranded 
DNA-binding protein B, SsbB, which protects them from degradation. In addi-
tion to bind to ssDNA, SsbB facilitates RecA-mediated recombination, and cre-
ates a pool of SsbB-ssDNA complexes that can undergo multiple recombination 
events. This last role stimulates chromosomal transformation and contributes to 
the genetic plasticity of S. pneumoniae (297). Mutations in this gene have been 
observed to negatively impact transformability showing the importance of SsbB 
in transformation (297). 
Then, the DNA processing A protein, DprA, replaces SsbB and promotes the 
loading of RecA onto the ssDNA (298). RecA plays a crucial role in the search for 
homology and in the strand-exchange reaction allowing the incorporation of the 
transforming DNA into the recipient genome (299). Assuming that the incoming 
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ssDNA presents sufficient homologous regions with the genome of the recipient 
bacteria, homologous recombination will occur. Additional competence-specific 
proteins, such RadA and CoiA, also favour transformation. RadA is a DNA helicase, 
which interacts with RecA and is loaded onto ssDNA. Subsequently, it unwinds 
the parental duplex DNA and translocates along the transforming ssDNA, facili-
tating its recombination (300). The function of CoiA is still not fully understood 
(301). General organization of the DNA uptake machinery is described in Figure 7.
Figure 7. Schematic representation of the components involved in DNA uptake and homologous 
recombination in S. pneumoniae. Used with permission from Muschiol et al. 2019 (302).
1.5.5.3 The comG operon
During competence, S. pneumoniae also expresses the comG operon, a set of 
late competence genes regulated by ComX. This operon is composed of seven 
genes, namely comGA, comGB, comGC, comGD, comGE, comGF, and comGG. All 
of them are required to express type IV pneumococcal competence pili on the 
bacterial surface, which are essential for transformation (278). The first gene of 
the operon, comGA, encodes a putative secretion ATPase responsible for providing 
the energy for pilus assembly. Inactivation of comGA leads to non-piliated pneu-
mococci (291). The next gene, comGB, encodes an integral membrane protein 
ComGB, thought to form the base structure. The remaining genes in the operon, 
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comGC-G, encode five pilin proteins. ComGC is the major pilin and it was shown 
to constitute the backbone of the competence pilus which can be 2-3 μm in length 
(291). Pneumococcal strains lacking comGC are non-piliated and non-transform-
able, suggesting that competence-induced pili are essential for transformation. 
DNA binding experiments suggested that the pneumococcal competence pilus 
functions as the primary DNA receptor on the surface of competent pneumococci 
(291). comGD, comGE, comGF and comGG encode four minor pilins whose role in 
pilus assembly and transformation remains elusive and investigating their role in 
DNA uptake is one of the aims of this thesis. The processing of the pneumococcal 
pilins is performed by the prepilin peptidase PilD, which is encoded by the pilD 
gene located elsewhere in the genome (303).
1.5.5.4 Fratricide - the killing mechanism
Competent pneumococci can target and acquire genetic material from non-
competent siblings. In bacterial cultures, this killing mechanism, named fratricide, 
allows the subpopulation of competent pneumococci to use the genetic material 
released as substrate in natural transformation (279). 
The product of the early competence gene comM and of the late competence 
genes cbpD, lytA and the σA-dependent gene lytC have been described as direct 
players in fratricide. Lysis is accomplished by the activity of the autolysin LytA, the 
lysozyme LytC and by the key fratricide cell wall hydrolase CbpD (24, 304). CbpD 
was shown to be crucial for fratricide and is also active against closely related 
species including S. mitis and S. oralis (304-306). In addition, it promotes the 
activity of lytic enzymes LytA and LytC in the target cells thereby stimulating and 
increasing the efficiency of lysis of non-competent bacteria. However, in contrast 
to CbpD, LytA and LytC, are not essential for fratricide (304, 306). Competent 
pneumococci protect themselves against self-lysis by expressing an immunity 
protein named ComM, which is encoded by an early competence gene [55, 61]. As 
result, the DNA released by non-competent siblings becomes available to be used 
in natural transformation by competent pneumococci. Thus, competence-induced 
fratricide may facilitate DNA repair through the transfer of homologous genetic 
material from non-competent pneumococci. Interestingly, in vitro studies suggest 
that DNA released during fratricide within biofilms leads to enhanced exchange 
of genetic material between pneumococci (307). In nature, it may favour gene 
transfer between closely related species in multispecies biofilms in the human 
nasopharynx allowing S. pneumoniae to adapt and survive in this environment. 
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1.5.5.5 The role of competence in pneumococcal pathogenesis
ComE and ComX control the two waves of gene expression observed during compe-
tence. ComE up-regulates a subset of early competence genes and ComX controls 
the expression of at least 80 late competence genes (278, 308). Interestingly, only 
23 genes were required for transformation of S. pneumoniae in laboratory condi-
tions (278). A systematic deletion analysis of ComX-regulated genes identified 14 
genes that were implicated in bacteremia and/or acute pneumonia in competitive 
or single mouse infection models (309). Among those, genes involved in stress 
response, cellular metabolism, and transport were identified. Mutants lacking 
genes required for fratricide, such as lytA, cbpD, and the bacteriocins cibA and 
cibB, were also less virulent in single-bacteremia infections and less competitive 
than WT in causing bacteremia and acute pneumonia in vivo. In addition, deletion 
of essential genes for genetic transformation including dprA and recA drastically 
reduced virulence in bacteremia and acute pneumonia models (309). Finally, in 
vivo competition assays of each late competence gene mutant in a ComX-null 
genetic background against the parental strain lacking ComX identified genes with 
basal expression levels (e.g. lytA) and competence-induced genes contributing 
to the bacterial fitness during infection (e.g. dprA) (309). In a recent follow-up 
study, it was shown that the ΔdprA mutant had a dysregulated overexpression of 
proteins involved in fratricide including LytA, CbpD and ComM. Overexpression 
of LytA and CbpD caused a higher susceptibility to lysis in the ΔdprA mutant in 
vitro. High levels of ComM led to growth arrest and reduced virulence in a mouse 
model of acute pneumonia. In addition, the inability of the mutant to shutdown 
competence was suggested to represent an energetic burden to the bacterium. 
Altogether, it was proposed that the deletion of DprA caused competitive disad-
vantages, which resulted in pneumococcal virulence attenuation in vivo (310). Loss 
of function in the early competence genes comB and comD also decreased the 
ability of S. pneumoniae to cause invasive diseases in mice (311, 312). Moreover, 
ComE was shown to negatively regulate the transcription of genes involved in 
the production of capsule in S. pneumoniae D39. Thus, deletion of comE led to 
increased transcription of capsule genes leading to a decrease in colonization 
fitness and enhanced virulence in adult mice models (313). In contrast, another 
study reported that deletion of ComE facilitated colonization in a newborn rat 
competitive colonization model of asymptomatic carriage (314). 
Analysis of the gene expression profiling during infection (pneumonia and sepsis) 
in vivo, showed that the competence genes comA, comE and comX were found to 
be less expressed during sepsis than in pneumonia conditions (312). Interestingly, 
it was also observed that the gene expression profiling of bacteria growing in 
biofilms in vitro was similar to the bacteria recovered from mice with pneumo-
nia. In contrast, bacteria grown in liquid cultured presented the same pattern of 
expression as bacteria recovered from septic mice. It was therefore suggested that 
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competence is involved in the regulation of distinct bacteria growth phenotypes, 
depending on the site of infection (312). 
Biofilm formation plays an important role in pneumococcal pathogenesis being 
involved in the transition from asymptomatic colonization to spread and disease 
(315). Recently, a new ComE-induced gene, named briC, was shown to encode a 
peptide which promotes biofilm formation in vitro and nasopharyngeal coloniza-
tion in vivo (316). Genetic exchange and the transformation efficiency were shown 
to be enhanced in biofilms growing in vitro under mimicking the conditions in the 
nasopharynx such as temperature and interaction with epithelial cells in vitro. 
In addition, co-colonization of mice with two pneumococcal strains resulted in 
higher transformation frequencies compared to a sepsis model (246).
Considering the importance of key competence proteins in pneumococcal viru-
lence, targeting these elements has been considered as a potential approach to 
control pneumococcal infections (317). Modified CSP peptides were reported to 
competitively inhibit competence and gene transfer as well as to attenuate viru-
lence of S. pneumoniae in vivo (318). Recently, a high-throughput screen identi-
fied inhibitors of pneumococcal competence, that block the proton motive force. 
When these inhibitors were used, the CSP export was disrupted which prevented 
competence and natural transformation in vitro in an epithelial colonization model 
and also reduced HGT in a mouse infection model (319).
1.6 Microfluidics and label-free particle sorting techniques 
Microfluidics is defined as a distinct area of research involving fluid manipulation 
in channels at the micrometre scale. This research area is relatively new with its 
origins towards the end of the 20th century. However, it has quickly emerged as a 
promising field considering its application in many other research areas such as 
biological, medical, and physical sciences (320). The vast range of available micro-
fluidic techniques allows its use from fundamental research to diagnostics. A key 
concept related to microfluidics is the possibility to develop lab-on-chip devices, 
which integrate different microfluidics principles with biological or chemical 
assays. Due to their portability and small dimensions, these devices provide the 
possibility of using small volumes and handling a large number of samples in a 
well-controlled manner and with high level of sensitivity. This allows a reduction 
of the overall costs and it shortens the time of experiments. However, a potential 
limiting factor is that the creation of such devices also requires the development 
of advanced fabrication techniques (321). 
The implementation of microfluidic techniques in the microbiology field has 
allowed us to study bacterial dynamics with further depth. Droplet microfluidics 
techniques have allowed investigations of phenotypic and genotypic  variations in 
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E. coli subpopulations for long periods of time. Individual bacteria were encapsu-
lated in droplets after a period of starvation and the development of each derived 
subpopulation was followed and characterized over time (322). Interestingly, 
another study using droplet microfluidics created a method to perform high-
throughput screening of antibiotic-resistant bacteria. This method allowed sorting 
and identification of mutants resistant to antibiotics by creating droplets where 
bacteria were grown in the presence of the bacteriostatic antibiotic fusidic acid. 
Only bacteria resistant to the antibiotic could proliferate and were then sorted 
based on their light-scattering properties (323). Moreover, a herringbone-type 
microfluidic platform containing an antimicrobial peptide on its surface was used 
to isolate Salmonella and Brucella spp. from large volumes (10 ml) of urine sam-
ples with a high-sensitivity degree (5 cfu/ml and 10 cfu/ml, respectively) (324). 
These examples highlight the importance and usefulness of designing microfluidic 
devices to study bacterial populations or to be applied in diagnostics.
One area which gained particular interest within microfluidics due to its numer-
ous biological applications is particle sorting. Cell sorting using microfluidics 
devices can be grouped into two categories: labelled techniques and label-free 
techniques. The first group of techniques exploit the use of labels or antibod-
ies, which can be coupled to the surface of the devices and be used to separate 
and enrich particles. This type of microfluidics techniques has been widely used 
in tumour biology and showed a high degree of sensitivity in the detection and 
sorting of circulating tumour cells (325-327). The second group of techniques 
exploits intrinsic physical properties of the biological particles to separate, with-
out the use of any type of label. This represents a great advantage compared to 
conventional sorting techniques such as flow cytometry or fluorescence activated 
cell sorting (FACS), allowing the recovery and use of the sample for downstream 
experiments (328). 
Microfluidic sorting, which uses label-free sorting and separation techniques 
can be further sub-grouped into two classes: active or passive methods. Active 
microfluidic techniques involve the application of external fields such as electric, 
magnetic or acoustic fields to sort particles according to their size and morpho-
logical properties. Examples of active techniques for particle sorting include 
acoustophoresis, electrophoresis and optical tweezers (329). In contrast, passive 
microfluidic methods do not require external force fields as they take advantage 
of intrinsic fluidic properties such as inertia or viscosity and also consider interac-
tions between particles in suspension. Some of the techniques included in this 
category are inertial microfluidic separation (iMF), pinched flow fractionation, and 
deterministic lateral displacement (DLD) (329). As the name suggests, iMF uses 
the inertial forces of particles to be sorted combined with the flow rate of the 
buffer where the particles are resuspended in. This technique has been used to 
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sort bacterial suspensions with bacteria migrating differently according to their 
size along the microchannels of the device (330). In pinched flow fractionation, 
particles are sorted by being pushed against the wall of the device as a result 
of the forces created by the buffer flow rate. This technique considers that a 
(spherical) particle cannot be closer to the wall of the device than its radius, thus 
particles with different sizes can be separated (331). Finally, particle sorting using 
DLD is obtained by running samples through an array of posts that will separate 
the particles according to their size. A more detailed description of this technique 
will be presented in the following section.
1.7 Deterministic lateral displacement - general principles
DLD was first described in 2004, in a study in which the authors separated differ-
ent spherical particles based on their size in continuous flow with a resolution 
down to 10 nm (332). Typically, DLD devices are one centimetre long, one mil-
limetre wide and 10 µm deep (Figure 8A). Their composition is relatively simple 
and can be divided into three parts: (i) a set of inlet reservoirs, (ii) a pillar array, 
and (iii) a set of outlet reservoirs. The particle sorting involves the loading of the 
mixed sample to be sorted in one of the inlets and running buffer in the other(s). 
This will ensure the creation of a proper laminar flow along the device. Then, the 
mixed sample runs through the pillar array where they will be sorted according to 
their size. Finally, the sorted sub-populations can be collected from the different 
outlet reservoirs for further analysis (Figure 8B) (333). 
The level of sorting efficiency strongly relies on the characteristics of the pillar 
arrays and the morphological properties of the particles. Each row of arrays is 
shifted from the previous row by a specific distance. This results in arrays that 
are not entirely aligned with the continuous flow which leads to the formation of 
different curvy streamlines that will allow particle separation (332). An important 
parameter that contributes to particle sorting is the critical diameter (DC) of the 
DLD device. The critical diameter of each device is calculated by using a specific 
formula, which takes into account the gap between two posts in a row and the 
row shift periodicity. Proper particle sorting is also affected by the depth of the 
device to avoid clogging, which is particularly important when sorting non-spher-
ical biological particles like bacteria. These parameters combined with the size 
distribution of the particles will ensure the correct separation of the particles in 
the device. Particles smaller than the critical diameter remain aligned within their 
initial streamline without being displaced and they assume a “zig-zag” trajectory. 
In contrast, particles larger than the critical diameter will be displaced gradually 
along the device in a displacement trajectory ending up in a different position 
than the particles migrating in “zig-zag” mode (Figure 8C) (333, 334).
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Figure 8. (A) Example of a DLD device used in this thesis. (B) Schematic representation of how a 
small particle (in green) and a larger particle (in red) migrate along the device. Adapted from (334) 
(C) Schematic representation of a DLD device with two inlets and five outlets used in this work, 
highlighting the outlets corresponding to the zig-zag mode and the displacement mode. Adapted 
from paper III.
1.7.1 Biological applications of DLD
DLD offers a large variety of throughput ranging from nanolitre per min (nl/min) 
to microlitre per minute (µl/min) which makes this technique an attractive solu-
tion to sort different types of biological samples. DLD devices have been used 
to sort white blood cells from red blood cells as well as circulating tumour cells 
from blood (335, 336). In addition, separation of parasites responsible for the 
human African trypanosomiasis (sleeping sickness) from human blood has also 
been accomplished by using this technique (337). Another promising prospect 
for DLD comes with the possibility to design and integrate devices to upstream 
and/or downstream applications. For instance, integrated high throughput devices 
using a combination of DLD arrays with an affinity-based technique allowed high 
yields of enrichment and capture of cancer cells from blood being an attractive 
approach for clinical cancer diagnosis (338).
1.7.2 DLD limitations 
Despite being a flexible and versatile technique, there are also some inherent 
limitations. DLD has been designed based on specific events, such as particle dif-
fusion, fluidic resistance and laminar flow, which become more prevalent at the 
microscale. In fact, diffusion and fluidic resistance are the two main challenges 
associated with the performance of DLD devices (333). Diffusion can disturb the 
laminar flow inside the device and may lead to particle mixing. For smaller particles 
running through the DLD devices, diffusion is usually residual and does not affect 
their trajectory. However, for larger particles diffusion may increase and affect 
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the separation efficiency. This can likely be overcome by a fine-tuned increase of 
the flow velocity. In addition, if the gap between the pillars is too small this may 
lead to additional fluid resistance in the device, which can make particles bind to 
the channel leading to device clogging (329). Clogging caused by the binding of 
biological particles to the surface of the device itself is also a matter of concern. 
Coating the devices with compounds that prevent particle-surface interactions 
but maintaining the intact morphology of the sample can overcome this problem.
Different modifications to the traditional DLD design have also been developed 
to minimize the limitations and to optimize the performance of the devices. 
Conventionally, the micropillars in the devices have a circular shape but a remark-
able variety of different micropillar shapes have been designed such as rectangular, 
triangular, and I-shaped microposts aimed to reduce clogging problems and to 
increase sorting efficiency (333). Recently, airfoil-shaped posts have also been 
optimized to increase the throughput and sorting of soft and deformable particles 
(339). After the validation of these alternative designs, it will be exciting to see 
their performance to sort different types of biological samples.
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2 AIMS
Natural transformation represents an important landmark in pneumococcal 
physiology and contributes to the remarkable genetic plasticity of this respiratory 
pathogen. It allows S. pneumoniae to acquire antibiotic resistances and evade 
vaccine pressure, making the infections caused by this pathogen hard to treat. 
Thus, understanding the underlying mechanisms of pneumococcal natural trans-
formation can help us to identify alternative approaches to tackle this pathogen. 
A crucial step in natural transformation is the uptake of extracellular DNA, which 
in S. pneumoniae involves the assembly of T4P. The main scope of this thesis was 
to study the composition of the competence pilus and for that we structurally 
characterized ComGC, the main building block of the pilus. Moreover, we wanted 
to investigate the role of the pneumococcal minor pilins in pilus biogenesis. The 
applicability of a label-free sorting technique to study pneumococcal subpopula-
tion was also investigated.
2.1 Specific aims
Paper I
To characterize the major pilin ComGC as the major component of the pneumo-
coccal competence pilus and to determine the molecular structure of this protein.
Paper II
To determine to role of the pneumococcal minor pilins ComGD, ComGE, ComGF 
and ComGG in competence pilus biogenesis and transformation.
Paper III
To sort and study pneumococcal subpopulations using the microfluidic label-free 




In this section, a general overview of the bacterial strains and methods used in 
the work of this thesis will be presented. For a detailed description of the pro-
tocols, please see the Material and Methods section of the respective papers. 
3.1 Growth conditions and bacterial strains 
S. pneumoniae was cultured in C medium with yeast (paper I) or in Todd-Hewitt 
Broth with yeast extract (paper II) at 37°C. In paper III, pneumococcal strains were 
grown on blood agar plates incubated overnight at 37°C in 5% CO2. In paper I and 
II, competence was induced by addition of competence stimulating peptide (CSP) 
at a final concentration of 100 ng/ml for 15 min.
Throughout the studies of this thesis, different pneumococcal strains were used: 
the encapsulated serotype 4, TIGR4, and its non-encapsulated isogenic derivate 
T4R are used in paper I. The non-encapsulated serotype 2, R6, was used in all 
papers and the encapsulated serotype 2, D39, was used in paper III.
In paper II, to generate pneumococcal in-frame deletion mutants, the fragment 
flanking the upstream and downstream regions of the target genes were ampli-
fied by PCR and ligated to a spectinomycin or erythromycin cassette. The resulting 
fragment was used to transform S. pneumoniae R6. Transformants were selected 
on blood agar plates containing the appropriate antibiotic and confirmed by PCR 
and sequencing. In addition, pneumococcal minor pilin mutants were constructed 
by ectopically expressing minor pilin(s) in the bgaA locus using integration vectors 
carrying pneumococcal minor pilin(s) that were transformed into S. pneumoniae 
R6. Transformants ectopically expressing minor pilin(s) in bgaA were selected on 
blood agar plates with tetracycline. Next, endogenous minor pilins were deleted 
accordingly by replacing the region of interest with a spectinomycin or erythro-
mycin cassette.
In paper III, bacteria grown on blood agar plates overnight were resuspended in 
a PBS solution containing 1% bovine serum albumin (BSA) at OD620nm = 1 before 
being sorted into different subpopulations.
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3.2 Characterization of the pneumococcal competence 
pilus and its function 
3.2.1 Transmission electron microscopy and immunogold 
labelling
Transmission electron microscopy and immunogold labelling was used to visual-
ize pili on competent S. pneumoniae R6. In paper I, primary antibody specific to 
ComGC and secondary antibody conjugated to 6 nm or 10 nm gold particles were 
used for immunogold labelling. In paper II, the incorporation and distribution 
of ComGF into the filament was evaluated by using anti-ComGF antibodies and 
secondary goat anti-rabbit antibody conjugated to 6-nm gold particles. 
3.2.2 Immunofluorescence microscopy
In paper II, competence pilus assembly in pneumococcal mutants was assessed 
by immunofluorescence microscopy. Competent bacteria were fixed and labelled 
with anti-ComGC primary antibody and Alexa 594 conjugated goat anti-rabbit sec-
ondary antibody (Life Technologies). The localization of the pneumococcal minor 
pilins was assessed similarly using anti-ComGD, anti-comGF, and anti-ComGG 
antibodies. A strain expressing an extra copy of flag tagged ComGF was used to 
co-stain competence pili with anti-Flag and anti-ComGC.
3.2.3 Transformation frequency
Transformation frequencies of the strains investigated in paper I and II were 
determined by using genomic DNA of S. pneumoniae carrying a streptomycin 
resistance mutation in the rpsL gene (340). Bacteria were grown until OD620 = 
0.15 and competence was induced with CSP for 15 min at 30 °C. DNA (1 µg/ml) 
was then added. Bacteria were incubated 30 min at 30 °C, followed by 60 min 
at 37 °C and were then plated on blood plates in the presence and absence of 
streptomycin. The blood plates were incubated overnight at 37 °C and 5% CO2 
before colony counting.
3.2.4 Bacterial Adenylate Cyclase Two Hybrid (BACTH) system
The BACTH system allows determination of protein-protein interactions by restor-
ing the activity of the Bordetella pertussis adenylate cyclase in E. coli reporter 
strains (341). In paper I and II, this approach was used to test ComGC-ComGC and 
ComGC-ComGG interactions, respectively. A detailed description can be found in 
paper I. The degree of interaction between pneumococcal pilins was measured as 
β-galactosidase activity, which was expressed in Miler units calculated from the 
following formula: 1000 x (OD420nm - 1.75 x OD550nm)/(incubation time (minutes) x 
volume (1 ml) x OD600nm).
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3.3 Protein expression and purification 
E. coli Rosetta (DE3) cells and E. coli T7 Express competent cells were used for 
heterologous expression of pneumococcal major and minor pilins, respectively. 
In paper I, His-tagged truncated ComGC was affinity purified, the His-tag was 
subsequently cleaved and untagged ComGC was further purified by size-exclusion 
chromatography. The sample was then used for nuclear magnetic resonance (NMR) 
studies and structure determination. In paper II, to test minor pilin interactions, 
untagged or GST-tagged soluble domains of each minor pilin were first expressed 
individually. Then, the pellet from a culture expressing an untagged pilin was 
mixed with the pellet expressing a GST-tagged pilin and each minor pilin combi-
nation was affinity purified and analysed by SDS-PAGE and Coomassie staining 
and immunoblotting. In addition, the minor pilin complex was also purified by 
affinity purification from an E. coli strain co-expressing all four minor pilins. The 
elution fraction was analysed by native polyacrylamide gel electrophoresis and 
Coomassie staining and detected bands were confirmed by mass spectrometry.
3.4 Co-immunoprecipitation of pneumococcal sheared pili
Co-immunoprecipitation assays were used in paper II to determine whether the 
pneumococcal minor pilins are associated with competence pili in S. pneumoniae 
R6. ComGC antisera was bound to Protein A Sepharose beads and incubated with 
sheared pili samples. Samples were analysed by SDS-PAGE and immunoblotting. 
3.5 Pneumococcal cell surface hydrophobicity 
The presence or absence of capsule is described to impact the hydrophobic char-
acter of the bacteria (342). In paper III, the cell surface properties of the encap-
sulated S. pneumoniae D39 and the non-encapsulated R6 were investigated by 
hydrocarbon adherence assay (343). 
3.6 Imaging and sorting of pneumococcal subpopulations 
To design devices suitable to sort R6 and D39, size measurements of these strains 
were performed on microscopy images taken of the cells grown overnight on 
blood agar plates. Devices were designed and optimized to sort S. pneumoniae 
R6 into subpopulations. To test the accuracy of this technique, sorting of the 
non-encapsulated R6 and the encapsulated D39 was also monitored. Time-lapses 
movies were taken from the samples running through the DLD device as well as 
movies of bacteria for each outlet. The movies from the outlets were used to 
blindly count the number of bacteria in each outlet according to their size allow-
ing an unbiased characterization of each subpopulation. 
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4 RESULTS AND DISCUSSION 
4.1 Paper I
Structure of the competence pilus major pilin ComGC in 
Streptococcus pneumoniae
S. pneumoniae is competent for natural genetic transformation, a feature that 
allows pneumococci to acquire new traits by taking up extracellular DNA from the 
surroundings and incorporating it into its genome by homologous recombination. 
During competence, S. pneumoniae R6 was shown to assemble T4P, which are 
composed of the major pilin ComGC (291). Thus, the first study included in this 
thesis biochemically characterized the major pilin ComGC in S. pneumoniae R6 
and TIGR4 strains. We investigated direct interactions between ComGC monomers 
and the ability of ComGC to oligomerize into high-molecular weight structures. 
In addition, we also determined the NMR structure of soluble ComGC.
To visualize pneumococcal competence pili, we used the non-encapsulated T4R 
strain deficient in sortase-mediated pili (T4RΔrrgA-srtD), to prevent the expression 
of other structures on the bacterial surface. Additionally, the non-encapsulated 
R6 strain was used, which naturally does not express sortase-mediated pili (344). 
After competence induction, both strains assembled filaments as visualized by 
transmission electron microscopy. The filaments were more abundant in com-
petent R6, which is why this strain was used for further microscopy studies. To 
show that ComGC forms the backbone of the pneumococcal competence pilus, 
immunogold labelling was performed using antibodies specific to ComGC and 
secondary antibody conjugated to 6 nm or 10 nm gold particles. The electron 
micrographs showed that gold particles labelled the entire pilus filament, indi-
cating that the major pilin ComGC is the main component of the pneumococcal 
competence pilus.  
To validate that ComGC can oligomerize into pili, we further analysed pili prepa-
rations by two-dimensional PAGE. When pili samples of competent WT bacteria 
were run on a native gel (first dimension) and subsequently immunoblotted with 
ComGC antibody, a high-molecular weight band was detected. Next, a lane from 
the native gel was cut and placed horizontally on top of an SDS-containing poly-
acrylamide gel (SDS-PAGE, second dimension). During PAGE, the SDS present in 
the gel denatured the high-molecular weight structure formed by ComGC, and 
when immunoblotted with anti-ComGC, a ladder-type pattern was observed. 
Due to partial denaturation, high-molecular ComGC but also monomeric ComGC 
and distinct oligomeric forms, which correspond to ComGC dimers and trimers, 
were observed. This further suggests, that ComGC can oligomerize and is able 
to form the backbone of the competence pilus. We further detected the direct 
50
interaction between two full-length ComGC monomers by using the bacterial 
adenylate cyclase two-hybrid system. Moreover, we could show in vitro that PilD 
can process full-length ComGC, when co-expressed in E. coli. Altogether, these 
results show that the major pilin ComGC has the intrinsic potential to oligomer-
ize and assemble into T4P. 
In addition to the biochemical characterization, we also studied the structural 
features of pneumococcal competence pili by analysing negatively stained trans-
mission electron micrographs. We determined that the average diameter of the 
filaments was 64 ± 1.6 Å, which is comparable to the diameter of T4P in N. gon-
orrhoeae (60 Å) but much larger than T4P in T. thermophilus, with a diameter of 
approximately 30 Å (132, 191). The differences observed are likely the result of 
structural differences of the major pilins, which can differ substantially in sequence 
and size. The observed competence pili also exhibited a high degree of flexibility 
and after analysing a large number of micrographs, a suitable number of straight 
regions in the filaments was identified and used to examine the potential helical 
symmetry in the filaments. Based on a class average power spectrum, it was pos-
sible to determine that the helical pitch of the pilus was approximately 40 Å. This 
suggests that pneumococcal T4P are somewhat less compact, when compared 
to the helical pitch of 37 Å of N. gonorrhoeae T4P. In contrast, pneumococcal pili 
are more compact than T4P in T. thermophilus, which have a helical pitch of 49 
Å (132, 191). 
The NMR structure of soluble ComGC solved in this study has shown distinct 
structural features. In Gram-negative bacteria, type IV pilins often present a “lol-
lipop-type” of conformation. However, ComGC is exclusively formed by α-helices 
(α1-C, α2 and α3) with a small head domain. Another important observation was 
the lack of cysteines in ComGC. Most type IV pilins have two cysteine residues 
in their C-terminal, which are involved in pilin stability and polymerization (107). 
This raises the question of how the pneumococcal competence pilus is stabilized. 
The lack of cysteines is not exclusive for S. pneumoniae, as the major pilin (PilA1) 
in C. difficile also lacks them. However, the structure of PilA1 differs from ComGC 
and it presents a more compact C-terminus stabilized by two β strands, which 
suggests distinct pilus stabilization strategies used by C. difficile and S. pneumo-
niae (345). The lack of structural stabilizing elements and the presence of a small 
head domain solely formed by α2 and α3 may explain the high level of ComGC 
flexibility observed. The highly dynamic properties of ComGC in solution may be 
an important characteristic for pilus assembly and function. 
When analysing the electrostatic potential of the solvent-accessible surface of 
ComGC, a well-defined electropositive cavity was identified along the N-terminal 
region of ComGC. The electropositive cavity contains exposed lysine and arginine 
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residues, which may contribute to DNA binding as observed for other DNA-binding 
proteins (346). This is an interesting observation that may help to understand how 
DNA is bound by competence pili. Interestingly, there was a recent attempt to 
model monomeric ComGC into a filament (175). The model hypothesized that the 
latter portion of the α1-N helix and the α1-C helix form a continuous α1, which 
form the core of the filament. The head domain formed by α2 and α3 is highly 
flexible, but by estimating the geometric centre (centroid) of the residues from 
α2 and α3, Piepenbrink suggested a pilus model with a diameter of approximately 
60 Å, somewhat similar to our observations (175). Interestingly, when comparing 
the structure of monomeric ComGC with this model, the electropositive patch 
would be surface-exposed, being consistent with our suggestion that this region 
has potential DNA binding properties.
In summary, the work presented in this paper represents the first structure of 
a major pilin protein from a competence system and provided initial structural 




Pneumococcal competence pilus assembly requires formation of a 
minor pilin complex
In the second study of this thesis, we further investigated the assembly of com-
petence pili in S. pneumoniae with particular focus on the pneumococcal minor 
pilins. In addition to ComGC, four minor pilins (ComGD, ComGE, ComGF and 
ComGG) are also encoded by the comG operon and expressed by competent 
pneumococci. Thus, we aimed at understanding the role of the pneumococcal 
minor pilins in competence pilus assembly and function. 
It is important to note that the genes of the comG operon are overlapping, mak-
ing the deletion of individual genes for further functional studies complicated. 
Consequently, we constructed in-frame deletion mutants lacking one or more 
minor pilins en bloc and evaluated their ability to assemble competence pili. This 
was assessed by immunoblotting and by analysing the levels of ComGC present in 
cell lysates and supernatants of the constructed minor pilin mutants. In general, 
lower levels of the major pilin ComGC were detected in all mutants but ComGC 
processing was not visibly affected. In addition, no ComGC was detected in the 
supernatant of these strains suggesting that pilus assembly was compromised. 
Since the competence pilus is essential for transformation, we also determined 
the transformation frequency of each minor pilin mutant and we confirmed that 
they were non-transformable compared to the WT strain. These results indi-
cate that the minor pilins are important for pilus assembly and function. Similar 
observations were reported in B. subtilis, which expresses a homologous comG 
operon (347, 348).
Next, we tested whether pilus assembly and function could be restored in a mutant 
lacking all four minor pilins by ectopically expressing individual pilins or pilin 
combinations in the bgaA locus. We observed that pilus assembly and transfor-
mation were only restored in the complemented strain expressing all four minor 
pilins. Interestingly, in the complementation strains expressing single comGG or 
comGDEFG the levels of ComGC in the cell lysates were similar to the WT strain 
suggesting that ComGG alone is able to stabilize ComGC. However, ComGG alone 
is not sufficient to restore pilus assembly and transformation.
Since ComGG was able to stabilize ComGC in absence of other minor pilins, we 
hypothesized that the two proteins would interact directly. By using the BACTH 
system implemented in paper I, we confirmed that full-length ComGC and ComGG 
interact directly. Considering that the presence of all minor pilins is required to 
assemble functional pili, we investigated whether there is a possible link between 
ComGG and other minor pilins. By immunoblotting, we observed that the stability 
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of ComGD and ComGF were strongly affected in a R6ΔcomGG strain. The stability 
of ComGE could not be assessed at this stage as the respective antisera failed to 
detect the protein in pneumococcal lysates. Altogether, these results indicate that 
ComGG also interacts with ComGD and ComGF and it is crucial for their stability.
Interactions between minor pilins have been reported in other systems (349, 350) 
and our data suggest that ComGG is likely to have a key role in the interaction 
with other pneumococcal minor pilins. This led us to evaluate the protein-protein 
interaction network among pneumococcal pilins in E. coli. For that, the soluble 
domains of each pilin, GST-tagged or untagged, were expressed independently. 
Next, we tested different binary pilin combinations by mixing and affinity purifying 
the pellets of untagged pilins with the pellets of each GST-tagged pilin. Our results 
indicate that the soluble domains of ComGD, ComGE, ComGF and ComGG can 
interact with each other. However, no interactions were detected in the affinity 
purification experiments using soluble GST-tagged ComGC. These results are in 
accordance with observations reported in other systems including B. subtilis and 
P. aeruginosa (349, 350), and also suggest that pneumococcal minor pilins are 
likely to form a minor pilin complex. To validate this hypothesis, we co-expressed 
all minor pilins in E. coli, which were then affinity purified. The eluate fraction was 
loaded onto a native gel and after Coomassie staining, a distinct band correspond-
ing to approximately 66 kDa was visible. Mass-spectrometry analysis confirmed 
that this band corresponded to a complex formed by the pneumococcal minor 
pilins. The formation of a minor pilin complex has also been reported in other 
systems like B. subtilis and P. aeruginosa (349, 350).
Next, we investigated the presence of minor pilins in cell lysates and sheared 
pili fractions in competent R6. We observed that ComGD, ComGF and ComGG 
can be found both in cell lysates and in sheared pili of competent R6. All three 
minor pilins were also detected after co-immunoprecipitation of sheared pili 
using anti-ComGC antibodies. In addition, by immunofluorescence and electron 
microscopy analysis we clearly visualized that ComGF is integrated throughout the 
competence pilus. Similarly, minor pilins in P. aeruginosa and Clostridium difficile 
were shown to be incorporated throughout T4P (345, 351). However, we were 
unable to detect ComGD and ComGG in the filaments assembled by competent 
R6, despite repeated attempts. This can be a result of the low abundance of these 
proteins in the filament or due to limited accessibility of the epitopes recognized 
by the antibodies. Considering our previous results that ComGG stabilizes ComGF 
and that minor pilins form a complex, we cannot rule out the presence of other 
minor pilins or the entire minor pilin complex in the filament.
The presence of the invariant E5 residue is a conserved feature among type IV 
pilins and it has been shown that a point mutation of E5 in ComGC (E5V) abolished 
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competence pilus assembly and transformation (291). Since all  pneumococcal 
minor pilins, except ComGG, present the invariant E5 residue we tested the 
role of the E5 residue present in ComGD, ComGE and ComGF in pilus assembly 
and transformation. All mutants carrying the E5A mutation presented similar 
amounts of ComGC in the cell lysates compared to the R6 strain suggesting that 
pilin processing is not affected. However, the levels of ComGC in sheared pili 
fractions showed variation among mutants. Competent pneumococci expressing 
ComGDE5A or ComGEE5A variants showed reduced levels of ComGC whereas bac-
teria expressing ComGFE5A presented only slightly decreased amounts of ComGC 
compared to the R6 strain. When the transformation frequency of those strains 
was determined, we observed a correlation with the amount of ComGC detected 
in the sheared pili and the transformability of each mutant. The transformation 
frequency was significantly lower in ComGDE5A and ComGEE5A mutants and no 
difference was observed in the ComGFE5A variant. Together, our results indicate 
that the E5 residue present in ComGD and ComGE is important for competence 
pilus biogenesis and function. 
Pneumococcal ComGG lacks the E5 residue and is larger than the major pilin 
ComGC. Similarly, other systems including the P. aeruginosa T4P and Klebsiella 
T2SS also present a large minor pilin lacking the E5 residue which is thought to be 
part of the pilus tip (352, 353). While we are lacking evidence for the presence of 
ComGG in the tip of the competence pilus, our data strongly suggest that ComGG 
is a key link between the major pilin and the minor pilin complex.
In summary, our results support the formation of a minor pilin complex to prime 
competence pilus formation and demonstrate a key role for ComGG as the linker 




Separation of pathogenic bacteria by chain length 
S. pneumoniae can grow in different cell arrangements, such as single cocci, diplo-
cocci or chains of variable lengths. Pneumococcal cell size has been associated 
with the ability to colonize or cause disease. Chain formation promotes adhe-
sion to epithelial cells in vitro and in vivo while short chains and single cocci have 
been associated with immune response evasion and meningitis in a mouse model 
(231, 232). Chaining mutants were also described to have a longer competence 
window in vitro when exposed to antibiotics, such as aztreonam and clavulanic 
acid (284). Competence induction has been linked to promote biofilm formation, 
which is associated with colonization in vivo, as well as to enhance virulence in 
mouse models of pneumonia (312, 316). Thus, the separation of pneumococci 
into subpopulations would enable to study the relation between competence 
and bacterial cell size in pneumococcal pathogenesis. Until now, label-free sort-
ing techniques like DLD have not been previously used to sort S. pneumoniae into 
distinct subpopulations. The third study in this thesis aimed therefore at testing 
the applicability of DLD to label-free sorting of S. pneumoniae subpopulations. 
The DLD devices used in this study were designed to sort the non-encapsulated 
S. pneumoniae R6 strain and the closely related encapsulated D39 strain into 
distinct subpopulations based on cell size and morphology. The devices were 9.5 
mm long with two inlets (one to load the bacterial sample and another to add 
the buffer) and five outlets, each one designed to collect a different bacterial 
fraction which was displaced differently in the device. The critical diameter of 
the device was 1.24 µm, which is larger than the average size of single cocci (≈1 
µm), smaller than the size of diplococci and chains, but larger than their length. 
Based on a previous study in which DLD was used to sort trypanosomes, the depth 
of the device was chosen to be approximately 10 µm (337). Both trypanosomes 
and pneumococcal chains can be considered as long thin biological particles; a 
depth of 10 µm is expected to increase the effective size of the chains allowing 
proper displacement of longer chains in relation to other morphologies (shorter 
chains, diplococci and single cocci). To prevent clogging of the device, a solution 
of poly(L-lysine)-g-poly(ethylene glycol) (PLL-g-PEG) was used to coat the devices 
and to create a hydrophilic surface that minimizes bacterial adhesion to the sur-
face and posts inside the device.
Bacterial solutions were prepared from pneumococci grown overnight on blood 
agar plates, resuspended in PBS containing 1% (w/v) BSA and adjusted to a final 
optical density (OD620nm) of 1. Before sorting, we characterized the input bacterial 
suspensions by measuring the cell size distribution of D39 (n=226) and R6 (n=146) 
cells. Overall, we observed that the encapsulated D39 strain presented in average 
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wider (1.09 mm vs 0.92 mm) and longer (1.43 mm vs 1.32 mm) cocci compared 
to the non-encapsulated R6, which could be related to the presence of capsule 
in the D39 strain. The D39 strain also formed longer chains compared to the R6 
strain (4.82 µm vs 3.78 µm). Remarkably, when we grouped the measurements 
for each strain into the different cell arrangements (single cocci, diplococci, and 
chains), we observed a substantial overlap in sizes between the different cell types. 
It is worth to note that in these experiments, we used bacteria grown overnight 
on blood agar plates. This is likely to result in bacteria in different stages in their 
replication cycle or in distinct metabolic stages depending on nutrient accessibility. 
It would be interesting to test synchronized cultures to determine whether these 
differences will still be observable. Next, we determined the proportion of each 
cell type in each unsorted sample. Both strains are mainly composed of diplococci, 
≈80% in the R6 strain and ≈60% in the D39 strain. Single cocci and chains were 
similarly distributed in the unsorted R6 strain while in the unsorted D39 strain, 
single cocci accounted for ≈30% of the sample and chains ≈10%.
Bacterial suspensions were sorted individually during 2.5 h during which movies 
from the outlets were taken to determine the ratio of single cocci, diplococci, 
and chains in each outlet reservoir. Sorting was run until the concentration of 
pneumococci in the outlets was sufficiently high to count tens to hundreds of 
bacteria unequivocally. At least 4 movies in distinct areas were taken per outlet. 
Then, the movies were randomized, analysed in a blind fashion to avoid bias in 
the characterization of each fraction, and the cell types were counted manually. 
Overall, we observed equivalent separation patterns in both strains. Single cocci 
were mostly found in outlets 1-3, which correspond to outlets in which bacteria 
were not, or little, displaced in the device. Chains were exclusively found in the 
outlets 4 and 5 and represent the fractions, which were displaced the most dur-
ing sorting. Diplococci were found in all outlets, with particular enrichment in 
the outlets collecting bacteria, which were displaced. Considering our previous 
measurements in which the length range of diplococci vastly overlapped with 
the length of chains (and to a smaller extent with single cocci), this result is not 
totally unexpected. This reflects the sensitivity of DLD to distinguish small varia-
tions in size. A possible way to circumvent this would be by increasing the length 
and the width of the array which would allow bacteria, especially diplococci and 
chains, to be sorted more efficiently. Alternatively, adjustments in the size of the 
gaps in the array could allow us to improve the purity of single cocci or chains.
Since the polysaccharide capsule represents a major virulence factor of S. pneu-
moniae, we sought to investigate whether we could separate the encapsulated 
strain D39 from the non-encapsulated strain R6. In order to distinguish the two 
strains following sorting, we used a GFP-labelled D39 strain. After sorting, we 
clearly observed an enrichment of fluorescent bacteria in the outlets 4 and 5. 
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The non-fluorescent R6 strain was found enriched and equally distributed in the 
outlets 1-3. As larger cells are expected to be displaced and to be collected pri-
marily in outlets 4 and 5, these observations are in line with our measurements 
showing that the D39 strain has overall larger cell sizes. It has been reported that 
the encapsulated D39 strain and a non-encapsulated variant presented distinct 
hydrophobic profiles in which the non-encapsulated strain was substantially more 
hydrophobic, estimated by ability to adhere to hexadecane (343). In accordance 
with these results, we observed that the non-encapsulated R6 strain displayed 
a higher hydrophobic character (42.4 ± 2.10% adherence to hexadecane) com-
pared to the D39 strain (2.7 ± 0.16% adherence to hexadecane). This may be an 
indication that D39 and R6 strains interact differently with the surface of the 
device. However, it remains unknown if the different hydrophobicity characters 
contributed to the sorting efficiency. 
During our experiments, we also followed the trajectories of pneumococci in the 
devices and observed that bacteria ran through them in several modes, which 
reflected in trajectories ranging from zero to maximum displacement. Larger par-
ticles, like chains, experienced rotation and bending due to their flexibility. While 
running in the device, chains moved in different modes, which can be triggered by 
different factors including variations in the particle shape and bending properties 
or fluctuations in the fluid flow. These different transport modes influence the 
effective size of bacteria and will lead to displacement or not. However, wider 
and longer particles like chains are more likely to move in modes that cause an 
increasing displacement and subsequently being sorted from smaller particles. 
Other factors including differences in deformability may also influence sorting, 
however, in this study, we did not evaluate if D39 and R6 strains were differently 
deformable. In summary, while hard spherical particles migrate only in two modes 
(zig-zag mode or displacement mode), the size, shape and orientation of non-
spherical biological particles like pneumococci preparations can vary leading to 
particles migrating differently depending on their effective size.
Sample recovery is a major challenge in many microfluidics devices including DLD 
(333). Importantly, we succeeded in recovering sorted samples from each out-
let, albeit in low concentrations, encouraging further optimizations that would 
increase sample recovery. The throughput of the device was estimated to be 1 
µl/h which can be optimized by using wider devices, larger spacing between posts, 
parallelization and fine-tuning the flow velocity. However, this needs to take in 
consideration for the sample concentration and duration of sorting to prevent 
clogging of the device.
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Finally, and equally important, we obtained a bacterial viability for each strain 
higher than 87% after running the sorting experiment for 2.5 hours. This is a crucial 
aspect to consider when thinking in downstream analysis of the subpopulations. 
To summarize, in this work we present solid evidence that DLD is a suitable tech-
nique to sort S. pneumoniae into different subpopulations. In addition, we show 
that the sensitivity of this technique allows separation of mixed pneumococcal 
cultures based on small morphological differences as the presence or absence 
of capsule. Thus, DLD also has the potential to be applied to sort pneumococcal 
isolates which often lack capsule and are serologically non-typeable (354, 355) 
into subpopulations to gain a deeper detail in the dynamics of colonization, a 
crucial requirement for invasive disease.
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5 CONCLUDING REMARKS 
Horizontal gene transfer plays a key role in the dynamics of bacterial genomes, 
and natural competence for transformation in S. pneumoniae vastly contributes 
to its genome plasticity. During competence, pneumococci assemble T4P, which 
are essential for natural transformation, making them crucial structures involved 
in the DNA uptake. Through natural transformation, S. pneumoniae can acquire 
antibiotic resistance genes and other advantageous traits that can improve its 
fitness and ability to colonize and cause disease. Consequently, a comprehensive 
understanding of the competence pilus biogenesis is required. 
In paper I, we gained a first structural understanding of the major component of 
the competence pilus. The NMR structure of ComGC revealed distinct features 
that differ from canonical type IV pilins. The assembly of long and flexible T4P may 
help pneumococci to capture DNA at long distances from the bacterial surface. 
This could provide an advantage to minimize repulsive electrostatic interactions 
between the transforming DNA and bacterial surface. Moreover, long and flex-
ible competence pili may facilitate better binding of DNA, leading to enhanced 
DNA uptake of that strain. Finally, identification of regions with potential DNA 
binding is an important feature to further investigate. A cryo-electron microscopy 
structure of the competence pilus and modeling of the individual subunits into 
this model would provide more information on how DNA is bound by the pilus. 
Interestingly, the high-resolution crystal structure of gonococcal PilE and 3D cryo-
electron microscopy reconstruction of the pilus filament led to the identification 
of positively charged grooves suitable to wrap DNA (191).
It is commonly believed that DNA uptake occurs at the pneumococcal mid cell 
coinciding with the site of peptidoglycan synthesis, which was proposed to facili-
tate DNA uptake through the thick peptidoglycan layer (294). The extension of 
the pilus through the cell wall still remains a puzzling question. Moreover, there 
is currently no evidence that the pneumococcal competence pilus retracts. In 
contrast to other T4P systems, the pneumococcal competence pilus system lacks a 
clear retraction ATPase. Interestingly, in C. crescentus, it was shown that tad-T4P, 
which lack a retraction ATPase, retract due to the action of a bifunctional ATPase 
that powers both pilus extension and retraction (128). Whether, pneumococcal 
ComGA could function as bifunctional ATPase that mediates both pilus extension 
and retraction, remains to be investigated. Alternatively, it has been shown that 
a minor pilin, most likely located at the tip of the pilus, promotes the retraction 
of TCP in V. cholerae (129). 
In paper II, we show that pneumococcal minor pilins are essential for natural 
transformation and unveiled a complex interaction network. We visualized that 
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ComGF is incorporated throughout the filaments, however; we cannot rule out 
that other minor pilins or the entire minor pilin complex can be part of the pilus. 
The atypical features of the minor pilin ComGG and its role as the linker between 
the major pilin and the minor pilin complex are also compatible with the idea 
that the minor pilin complex could be located at the tip of the pilus, possibly to 
promote the binding of DNA and/or pilus retraction. Clearly, more experimental 
evidence is needed to investigate this possibility.
While the competence pilus is not required for virulence in S. pneumoniae D39, 
which under laboratory conditions has a low transformability rate, deletion of 
the major pilin comGC in hyper-transformable pneumococcal isolates affected 
colonization and virulence in vivo (309, 356). Thus, deciphering the molecular 
details of how DNA is taken up by pneumococci will help to identify possible inno-
vative approaches to tackle pneumococcal infections. Compounds active against 
T4P-related functions, such as twitching motility and bacterial aggregation, have 
being identified in pathogenic Neisseria species and P. aeruginosa (357). In N. 
meningitidis, these compounds interfered with the sodium gradient, and pos-
sibly with the proton motive force, through the inner membrane and promoted 
pilus retraction over pilus extension through a yet unknown mechanism (357). 
Interestingly, pneumococcal competence inhibitors disrupting the proton motive 
force and CSP export have also been recently identified (319). 
Moreover, the pneumococcal competence regulon also plays an important role in 
regulating pneumococcal colonization and virulence. There is also evidence that 
the size of pneumococci is important in the interplay between colonization and 
invasive disease. Thus, separating S. pneumoniae into distinct subpopulations 
based on their size could be an interesting approach to study how competence 
is regulated at subpopulation level and how this would impact colonization and 
virulence. In paper III, we validated the applicability of microfluidics to study S. 
pneumoniae and believe that this approach has great potential to further study 
pneumococcal colonization and invasive disease properties at subpopulation level.
In conclusion, the work included in this thesis has laid a basic foundation to better 
understand the importance of pneumococcal competence pili, not only in DNA 
uptake but also in the pathogenesis of this bacterium. Moreover, we identified 
DLD as an attractive technique, which offers the possibility to further study the 
link between competence, colonization, and virulence based on the morphologi-
cal properties of pneumococci.
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